+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 45204

Chapter 45204 contains a list of PDF Full Texts available from EurekaMag.

Donati, D.; Giacomini, S.; Gozzi, E.; Salphale, Y.; Mercuri, M.; Mankin, H.J.; Springfield, D.S.; Gebhardt, M.C., 2002:
Allograft arthrodesis treatment of bone tumors: a two-center study

Randhawa, P., 2002:
Allograft biopsies in management of pancreas transplant recipients

Clayer, M.; Oakeshott, R., 1994:
Allograft bone in the treatment of desmoplastic fibroma. A case report

Khan, M.T.; Stockley, I.; Ibbotson, C., 1998:
Allograft bone transplantation: a Sheffield experience

Blanco, J.S.; Sears, C.J., 1997:
Allograft bone use during instrumentation and fusion in the treatment of adolescent idiopathic scoliosis

Yankah, A.C.; Wottge, H.U., 1997:
Allograft conduit wall calcification in a model of chronic arterial graft rejection

Miller, L.W., 1997:
Allograft coronary disease: the role of antigen independent mechanisms in pathogenesis

Clarke, D.R.; Bishop, D.A., 1993:
Allograft degeneration in infant pulmonary valve allograft recipients

Dubin, M.G.; Feldman, M.; Ibrahim, H.Z.; Tufano, R.; Evans, S.M.; Rosenthal, D.; Wolf, P.F.; Weber, R.S., 2000:
Allograft dermal implant (AlloDerm) in a previously irradiated field

Abraczinskas, D.R.; Chung, R.T., 2001:
Allograft dysfunction and hyperbilirubinemia in a liver transplant recipient

Schmidt, T.L.; Cimino, W.G.; Seidel, F.G., 1996:
Allograft epiphysiodesis for slipped capital femoral epiphysis

Zhou, Y.; Wang, Y.; Bai, X.; Liu, Z.; Xiao, S.; Liu, B.; Lu, S., 2002:
Allograft fibula in treatment of cervical spondylosis

Sorger, J.I.; Hornicek, F.J.; Zavatta, M.; Menzner, J.P.; Gebhardt, M.C.; Tomford, W.W.; Mankin, H.J., 2001:
Allograft fractures revisited

Pratt, J.R.; Hibbs, M.J.; Laver, A.J.; Smith, R.A.; Sacks, S.H., 1996:
Allograft immune response with sCR1 intervention

Poindexter, N.; Shenoy, S.; Howard, T.; Flye, M.W.; Mohanakumar, T., 1997:
Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens

Plunkett, M.D..; Bond, L.M..; Geiss, D.M.., 2001:
Allograft mitral valve replacement

Tian, L.; Zhan, J.; Wang, S., 1999:
Allograft of frozen nerve in repairing sensory nerve defect

Stratta, R.J.; Gaber, A.O.; Shokouh-Amiri, M.H.; Reddy, K.S.; Egidi, M.F.; Grewal, H.P., 2000:
Allograft pancreatectomy after pancreas transplantation with systemic-bladder versus portal-enteric drainage

Ciancio, G.; Montalvo, B.; Roth, D.; Miller, J.; Burke, G.W., 2002:
Allograft pancreatic duct dilatation following bladder drained simultaneous pancreas-kidney transplantation: clinical significance

Harris, A.I.; Gitelis, S.; Sheinkop, M.B.; Rosenberg, A.G.; Piasecki, P., 1994:
Allograft prosthetic composite reconstruction for limb salvage and severe deficiency of bone at the knee or hip

Brien, E.W.; Terek, R.M.; Healey, J.H.; Lane, J.M., 1994:
Allograft reconstruction after proximal tibial resection for bone tumors. An analysis of function and outcome comparing allograft and prosthetic reconstructions

Mnaymneh, W.A.; Temple, H.Thomas.; Malinin, T.I., 2002:
Allograft reconstruction after resection of malignant tumors of the scapula

Bell, R.S.; Davis, A.M.; Wunder, J.S.; Buconjic, T.; McGoveran, B.; Gross, A.E., 1997:
Allograft reconstruction of the acetabulum after resection of stage-IIB sarcoma. Intermediate-term results

McAllister, C.M.; Borden, L.S., 1993:
Allograft reconstruction of the acetabulum in revision hip surgery

Noyes, F.R.; Barber, S.D., 1993:
Allograft reconstruction of the anterior and posterior cruciate ligaments: report of ten-year experience and results

Kulkarni, S.; Sawant, M.; Ireland, J., 1999:
Allograft reconstruction of the extensor mechanism for progressive extensor lag after total knee arthroplasty and previous patellectomy: a 3-year follow-up

Willems, T.P.; Bogers, A.J.; Cromme-Dijkhuis, A.H.; Steyerberg, E.W.; van Herwerden, L.A.; Hokken, R.B.; Hess, J.; Bos, E., 1996:
Allograft reconstruction of the right ventricular outflow tract

Fisher, L.R.; Henley, K.S., 1998:
Allograft rejection after liver transplantation for autoimmune diseases

Hayashi, M.; Keeffe, E.B.; Krams, S.M.; Martinez, O.M.; Ojogho, O.N.; So, S.K.; Garcia, G.; Imperial, J.C.; Esquivel, C.O., 1998:
Allograft rejection after liver transplantation for autoimmune liver diseases

Girard, L.J.; Esnaola, N.; Rao, R.; Barnett, L.; el Maghraby, A.; Canizales, R., 1993:
Allograft rejection after penetrating keratoplasty for keratoconus

Fine, R.N., 1994:
Allograft rejection in growth hormone and non-growth hormone treated children

Toyoki, Y.; Renz, J.F.; Mudge, C.; Ascher, N.L.; Roberts, J.P.; Rosenthal, P., 2002:
Allograft rejection in pediatric liver transplantation: Comparison between cadaveric and living related donors

Nishida, S.; Komokata, T.; Ogata, S.; Ikoma, A.; Hamada, N.; Matsumoto, H.; Ushijima, T.; Tanaka, K.; Yoshida, H.; Taira, A., 1998:
Allograft rejection of small bowel transplantation in pigs

Patradul, A.; Kitidumrongsook, P.; Parkpian, V.; Ngarmukos, C., 2001:
Allograft replacement in giant cell tumour of the hand

Ladowski, J.S.; Deschner, W.P., 1996:
Allograft replacement of the aortic valve for active endocarditis

Nichani, A.K.; Brown, C.G.; Campbell, J.D.; Maxwell, M.H.; Waddington, D.; Spooner, R.L., 1997:
Allograft responses can interfere with the development of immunity against Theileria annulata following vaccination with parasite infected cell lines

Scarborough, N.L.; White, E.M.; Hughes, J.V.; Manrique, A.J.; Poser, J.W., 1995:
Allograft safety: viral inactivation with bone demineralization

Foulkes, G.D.; Mitsunaga, M.M., 1993:
Allograft salvage of failed total elbow arthroplasty. A report of two cases

Ghoniem, G.M., 2000:
Allograft sling material: is it the state of the art?

Hernigou, P., 2000:
Allograft sterility as exemplified by human immunodeficiency virus and sterilization by irradiation

Terness, P.; Dufter, C.; Otto, G.; Opelz, G., 1996:
Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognition

Connolly, L.P.; Connolly, S.A.; Treves, S.T., 2001:
Allograft tibial plateau fracture

Wahoff, D.C.; Papalois, B.E.; Nelson, L.A.; Leone, J.P.; Everett, J.A.; Sutherland, D.E., 1996:
Allograft tolerance by intrathymic donor splenocyte transfer: an age-dependent, species-specific phenomenon?

Gao, Z.H.; Lazarovits, A.I.; Wang, J.; Xing, J.; Garcia, B.; Kellersmann, R.; Kelvin, D.; Zhong, R., 2000:
Allograft tolerance induced by cyclophosphamide without prior inoculation of donor cells--immune suppression and redirection

Wang, J.W.; Shih, C.H., 1993:
Allograft transplantation in aggressive or malignant bone tumors

Avella, A.; Pucci, E.; Di Segni, M.; Dini, P., 1999 :
Allograft typical atrial flutter: transesophageal recording in an orthotopic cardiac transplant patient

Jervis, J.Johnstone., 1911:
Adrenalin in Asthma

Trivedi, S.; Mullasari, A.S.; Arumugam, S.B.; Cherian, K.M., 2000:
Allograft vasculopathy in cardiac transplant recipients: an early experience

Kerber, S.; Rahmel, A.; Karbenn, U.; Heinemann-Vechtel, O.; Fechtrup, C.; Lamp, B.; Block, M.; Budde, T.; Hoffmeier, A.; Weyand, M., 1994:
Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings

Young, J.B., 1999:
Allograft vasculopathy: diagnosing the nemesis of heart transplantation

Harner, C.D.; Olson, E.; Irrgang, J.J.; Silverstein, S.; Fu, F.H.; Silbey, M., 1996:
Allograft versus autograft anterior cruciate ligament reconstruction: 3- to 5-year outcome

Vettenranta, K.; Hovi, L.; Taskinen, M.; Saarinen-Pihkala, U., 2000:
Allograft with unrelated donor accentuates the gastrointestinal toxicity associated with high-dose melphalan and total body irradiation preparative for bone marrow transplantation in children

Starzl, T.E., 1998:
Allograft "acceptance" and tolerance: a new concept

Scarborough, M.T., 2001:
Allograft-allograft healing? Salvage of massive allografts after fracture

Schluesener, H.J.; Seid, K.; Kretzschmar, J.; Meyermann, R., 1998:
Allograft-inflammatory factor-1 in rat experimental autoimmune encephalomyelitis, neuritis, and uveitis: expression by activated macrophages and microglial cells

Wang, Z.; Huang, Y.; Hu, Y.; Ma, P.; Wang, Q.; Yu, H.; Liu, J.; Ma, Z.; Zhang, Y., 2002:
Allograft-prosthesis combination in limb salvage surgery

Zehr, R.J.; Enneking, W.F.; Scarborough, M.T., 1996:
Allograft-prosthesis composite versus megaprosthesis in proximal femoral reconstruction

Habiballah, J.A.; Bamousa, A., 2001:
Allograftic and alloplastic auricular reconstruction

Clift, R.A.; Anasetti, C., 1997:
Allografting for chronic myeloid leukaemia

Savage, D.G.; Goldman, J.M., 1997:
Allografting for chronic myeloid leukemia

Toze, C.L.; Shepherd, J.D.; Connors, J.M.; Voss, N.J.; Gascoyne, R.D.; Hogge, D.E.; Klingemann, H.G.; Nantel, S.H.; Nevill, T.J.; Phillips, G.L.; Reece, D.E.; Sutherland, H.J.; Conneally, E.A.; Barnett, M.J., 2000:
Allografting for indolent lymphoid neoplasms

Liu, J.Z.; Wang, Z.; Li, M.Q., 2001:
Allografting for massive bone defect: bone and soft tissue reconstruction and postoperative rehabilitation

Stuchin, S.A., 1993:
Allografting in total knee replacement arthroplasty

Reikeraas, O.; Folleraas, G.; Winge, J.F., 1998:
Allografting in uncemented acetabular revision

Santini, F.; Mazzucco, A., 1994:
Allografts for outflow tract reconstruction in pediatric patients

Villas, C.; Beguiristain, J.L.; Mora, G.; Calvo, R.; Valdés, G., 1996:
Allografts in extensive spinal arthrodesis

Broadwell, R.D.; Baker, B.J.; Ebert, P.S.; Hickey, W.F., 1994:
Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations

Randhawa, P.S.; Starzl, T.; Ramos, H.C.; Nalesnik, M.A.; Demetris, J., 1994:
Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies

Li, F.K.; Chan, T.M.; Lai, K.N., 2001:
Alloimmune hemolysis after renal transplantation

Buznego Sánchez, R.; Viñuela Roldán, J.E.; Couce Pico, M.L.; Saavedra Pereira, M.J.; Fernández Lorenzo, J.R.; Fraga Bermúdez, J.M., 1996:
Alloimmune neonatal neutropenia due to anti-NA1 antibodies

Rodwell, R.L.; Tudehope, D.I.; O'Regan, P.; Minchinton, R.; Waters, A.H., 1991:
Alloimmune neonatal neutropenia in Australian aboriginals: an unrecognized disorder?

Bux, J.; Hartmann, C.; Mueller-Eckhardt, C., 1994:
Alloimmune neonatal neutropenia resulting from immunization to a high-frequency antigen on the granulocyte Fc gamma receptor III

Ruggiero, A.; Pesaresi, A.; Scommegna, S.; Giordano, P.; Mastrangelo, S.; Riccardi, R., 1999:
Alloimmune neonatal neutropenia treated with rHuG-CSF

Cedena Romero, P.; Muro Brussi, M.; García Alonso, L.; Muñiz Díaz, E.; Cabanillas Vilaplana, L.; Sáez Pérez, E., 1996:
Alloimmune neonatal neutropenia. Treatment with granulocyte colony- stimulating factor

Puig, N.; Montoro, J.A.; Villalba, J.L.; Gimeno, M.; Ample, I.; Molina, J.; Sagaseta, M.; Asensio, A., 1993:
Alloimmune neonatal neutropenia: flow cytometry study of the 1st patient described in Spain with identification of an anti-NA1

Rogowska, A.; Klimaszewska, A.; Cynkier, D.; Radziwon, P., 1996:
Alloimmune neonatal thrombocytopenia caused by serologic incompatibility of HPA-1a platelet antigen--case report

Brand, A., 2001:
Alloimmune platelet refractoriness: incidence declines, unsolved problems persist

Sandler, S.G., 1997:
Alloimmune refractoriness to platelet transfusions

Kekomäki, S.; Salmela, K.; Partanen, J.; Koskimies, S.; Kekomäki, R., 1997:
Alloimmunization against platelet antigens in renal transplant patients with acute vascular rejection

Shearer, G.M.; Clerici, M.; Dalgleish, A., 1993:
Alloimmunization as an AIDS vaccine?

So, C.C.; Wong, K.F.; Yu, P.H.; Kwan, A.M.; Lee, A.W., 2000:
Alloimmunization in Chinese with warm autoimmune haemolytic anaemia - incidence and characteristics

Strauss, R.G.; Johnson, K.; Cress, G.; Cordle, D.G., 2001:
Alloimmunization in preterm infants after repeated transfusions of WBC-reduced RBCs from the same donor

Kiprov, D.D.; Sheppard, H.W.; Hanson, C.V., 1994:
Alloimmunization to prevent AIDS?

Josebe Unzaga, M.; Rojo, P.; Pardo, C.; Melero, P.; Cisterna, R., 1997 :
Alloiococcus otitidis: a more common microorganism than we thought?

Calegaro-Marques, C.; Bicca-Marques, J.C., 1993:
Allomaternal care in the black howler monkey (Alouatta caraya)

George, K.; Sharma, S.; Batterham, A.; Whyte, G.; McKenna, W., 2000:
Allometric analysis of the association between cardiac dimensions and body size variables in 464 junior athletes

Frahm, H.D.; Rehkämper, G., 1998:
Allometric comparison of the brain and brain structures in the white crested polish chicken with uncrested domestic chicken breeds

Batterham, A.M.; George, K.P., 1998:
Allometric modeling does not determine a dimensionless power function ratio for maximal muscular function

Gauld, S.C., 1996:
Allometric patterns of cranial bone thickness in fossil hominids

Tazawa, H.; Pearson, J.T.; Komoro, T.; Ar, A., 2000:
Allometric relationships between embryonic heart rate and fresh egg mass in birds

Dreyer, O., 2001:
Allometric scaling and central source systems

Vollmer, S.V.; Edmunds, P.J., 2000:
Allometric scaling in small colonies of the scleractinian coral Siderastrea siderea (Ellis and Solander)

Beuchat, C.A., 1998:
Allometric scaling laws in biology

Hu, T.M.; Hayton, W.L., 2002 :
Allometric scaling of xenobiotic clearance: uncertainty versus universality

Makarova, N.K.; Isakevich, V.V.; Simonova, N.I., 1997:
Allometric signals of technogenic actions on the population

Yamashita, M.; Naitoh, T.; Kashiwagi, A.; Kondo, Y.; Wassersug, R.J., 2001:
Allometry in vestibular responses of anurans

Batterham, A.M.; Birch, K.M., 1996:
Allometry of anaerobic performance: a gender comparison

Dol'nik, V.P., 2001:
Allometry of reproduction in poikilotherm and homoiotherm vertebrates

Singh, G.D.; McNamara, J.A.; Lozanoff, S., 1999:
Allometry of the cranial base in prepubertal Korean subjects with class III malocclusions: finite element morphometry

Eichholz, A.C.; Mahavni, V.; Sood, A.K., 2002:
Allopathic and complementary alternatives to hormone replacement therapy

McPartland, J.M., 1993:
Allopathic medical research echoes earlier findings in osteopathic medicine

Jones, A.H., 2001:
Allopathic medicine gone awry

Klotz, L.H., 2000:
Allopathic versus 'holistic' medicine

Fändrich, F.; Dresske, B.; Lin, X.; Huang, D.S.; Zavazava, N.; Henne-Bruns, D., 1999:
Allopeptide-mediated expression of endothelial Fas-ligand (CD95L) in long-term tolerized heterotopic rat heart grafts

Mandpe, A.H.; Singer, M.I.; Kaplan, M.J.; Greene, D., 1998:
Alloplastic and microvascular restoration of the mandible: a comparison study

Urban, J., 1993:
Alloplastic augmentation in reconstruction of the knee joint ligaments

Louis, P.J.; Cuzalina, L.A., 2001:
Alloplastic augmentation of the face

Semergidis, T.G.; Migliore, S.A.; Sotereanos, G.C., 1996:
Alloplastic augmentation of the mandibular angle

Seitz, H.; Wielke, B.; Schlenz, I.; Pichl, W.; Vecsei, V., 1996:
Alloplastic augmented femoral reinserted anterior cruciate liganent. Value of 2 channel augmentation for postoperative rehabilitation

Lembcke, O.; Brutscher, R.; Rüter, A., 1996:
Alloplastic bone replacement in resection defects of the long bones

Mitcherling, J.J.; Mitcherling, W.W.; Johnson, R.K., 1998:
Alloplastic implant and bioabsorbable fixation devices

Eppley, B.L., 1999:
Alloplastic implantation

Taylor, T.D.; Rieger, W.P., 1994:
Alloplastic implants. Their role in reconstruction of the mandible

Meyer, D.R., 1995:
Alloplastic materials for orbital surgery

Byrd, H.S.; Hobar, P.C., 1996:
Alloplastic nasal and perialar augmentation

Tawfilis, A.R.; Chappell, E.Thomas.; Farhood, V.W., 2002:
Alloplastic reconstruction of a temporal bone and glenoid fossa defect

Maurer, K.P.; Refior, H.J., 1996:
Alloplastic replacement of the proximal femur--indications, results and experiences

Meyer, M.; Neef, H.; Zerkowski, H.R., 1999:
Alloplastic sternal replacement in malignant sternal tumors. Case report and review of the literature

Hwang, K.; Kita, Y., 2002:
Alloplastic template fixation of blow-out fracture

Eppley, B.L., 2001:
Alloplastic tumor of the palate: view from the operating room

Gierek, T.; Gruszka, M.; Markowski, J.; Iwanowski, P.; Majzel, K., 2000:
Alloplastic valve vocal prosthesis to serve for rehabilitation speech after total laryngectomy

Seare, W.J., 2000:
Alloplasts and biointegration

Baiazitov, N.R., 2001:
Alloplasty efficacy in the treatment of giant postoperative and recurrent abdominal hernia

Feleshtinskiĭ, I.P., 1999:
Alloplasty of giant postoperative abdominal hernia in middle aged and aged patients

Sneppen, O.; Søballe, K., 2000:
Alloplasty. Development of well-functioning and durable joint implant--a biomechanical and biological challenge

Murphy, B.E., 2001:
Allopregnanolone assays

Kajta, M.; Budziszewska, B.; Lasoń, W., 2000:
Allopregnanolone attenuates kainate-induced toxicity in primary cortical neurons and PC12 neuronal cells

Cabrera, R.J.; Bregonzio, C.; Laconi, M.; Mampel, A., 2003:
Allopregnanolone increase in striatal N-methyl-D-aspartic acid evoked [3H]dopamine release is estrogen and progesterone dependent

Ferrer, J.V.; Ariceta, J.; Guerrero, D.; Gomis, T.; Larrea, M.M.; Balén, E.; Lera, J.M., 1998:
Allopurinol and N-acetylcysteine avoid 60% of intestinal necrosis in an ischemia-reperfusion experimental model

Fernandez, G.; García, J.E.; Ahijado, F.; Diaz-Tejeiro, R.; Gonzalez, E.; Gómez, E.; Sierra, T., 1993:
Allopurinol and bone marrow aplasia

Riaz, A.A.; Wan, M.X.; Schäfer, T.; Dawson, P.; Menger, M.D.; Jeppsson, B.; Thorlacius, H., 2002:
Allopurinol and superoxide dismutase protect against leucocyte-endothelium interactions in a novel model of colonic ischaemia-reperfusion

Jappe, U.; Franke, I.; Wendekamm, U.; Gollnick, H., 1998:
Allopurinol as an inducer of acute graft-versus-host-like drug reaction. Case report with review of the literature

Tarkka, M.R.; Kaukinen, S.; Holm, P.; Kaukinen, U.; Sisto, T.; Kataja, J.; Huang, W.Q., 2000:
Allopurinol does not increase free radical scavenging capacity during reperfusion in coronary artery bypass graft patients

Smeets, H.J.; Dulfer, F.T.; van Milligen de Wit, A.W.; Camps, J.; Kievit, J.; Van Bockel, J.H.; Hermans, J.; Berger, H.M., 1997:
Allopurinol dosage and effect on ischemia-reperfusion damage in elective and acute aortic surgery

McNaughton Collins, M.; Wilt, T., 2000:
Allopurinol for chronic prostatitis

Nickel, J.C.; Siemens, D.R.; Lundie, M.J., 1996:
Allopurinol for prostatitis: where is the evidence?

Lara, D.R.; Cruz, M.R.S.; Xavier, F.; Souza, D.O.; Moriguchi, E.H., 2002:
Allopurinol for the treatment of aggressive behaviour in patients with dementia

Grus, F.H.; Augustin, A.J.; Loeffler, K.; Dick, B.; Lutz, J.; Pfeiffer, N., 2001:
Allopurinol has immunomodulating activity following topical and systemic application in experimental autoimmune uveitis

Chan, Y.C.; Tay, Y.K.; Ng, S.K., 2002:
Allopurinol hypersensitivity syndrome and acute myocardial infarction--two case reports

Karwinski, W.; Søreide, O., 1997:
Allopurinol improves scavenging ability of the liver after ischemia/reperfusion injury

Pfau, A.; Stolz, W.; Karrer, S.; Szeimies, R.M.; Landthaler, M., 1998:
Allopurinol in treatment of cutaneous sarcoidosis

Shinagawa, A.; Itoh, T.; Komeno, T.; Komatsu, T.; Hasegawa, Y.; Kobayashi, T.; Kozima, H.; Ninomiya, H.; Nagasawa, T.; Abe, T., 1997:
Allopurinol induced pancytopenia in a patient with myeloproliferative disorder

Gorrie, M.; Beaman, M.; Nicholls, A.; Backwell, P., 1994:
Allopurinol interaction with cyclosporin

Yildirim, S.; Tok, H.; Köksal, H.; Erdem, L.; Baykan, A., 2002:
Allopurinol plus pentoxifilline in hepatic ischaemia/reperfusion injury

Krasna, I.H.; Lee, R.T., 1993:
Allopurinol protects the bowel from necrosis caused by indomethacin and temporary intestinal ischemia in mice

Matsumoto, F.; Sakai, H.; Yamaguchi, M.; Nakano, H.; Matsumiya, A.; Kumada, K.; Yoshida, K.; Shimura, H.; Machida, H.; Takeuchi, S.; Sasaya, S.; Midorikawa, T.; Sanada, Y., 1997:
Allopurinol reduced hepatic ischemia-reperfusion injury exacerbated by inhalation of high-concentration oxygen in rats

Iwata, H.; Akamatsu, S.; Minami, N.; Yamada, M., 2000:
Allopurinol, an inhibitor of xanthine oxidase, improves the development of IVM/IVF bovine embryos (>4 cell) in vitro under certain culture conditions

Acevedo-Chávez, R.; Costas, Mía.Eugenia.; Escudero, R., 1996:
Allopurinol- and Hypoxanthine-Copper(II) Compounds. Spectral and Magnetic Studies of Novel Dinuclear Coordination Compounds with Bridging Hypoxanthine

Lun, K.; Harley, W., 2002:
Allopurinol-induced pustular eruption: an unusually mild case

Boffa, M.J.; Chalmers, R.J., 1994:
Allopurinol-induced toxic pustuloderma

Smith, K.D.; Lutz, C.T., 1997:
Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices

Hornell, T.M.; Solheim, J.C.; Myers, N.B.; Gillanders, W.E.; Balendiran, G.K.; Hansen, T.H.; Connolly, J.M., 1999:
Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I alpha-helical residues

Sirak, J.; Orosz, C.G.; Wakely, E.; VanBuskirk, A.M., 1997:
Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection

Mavoungou, E.; Sall, A.; Poaty-Mavoungou, V.; Toure, F.S.; Yaba, P.; Delicat, A.; Lansoud-Soukate, J., 1999:
Alloreactivity and association of human natural killer cells with the major histocompatibility complex

Russell, C.Astrid., 2002:
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation

Gallardo, D.; Rojas, I.; Domínguez, E.; Madrigal, A., 1997:
Alloreactivity and umbilical cord blood transplantation

Côté, I.; Rogers, N.J.; Lechler, R.I., 2001:

Spierings, E.; Vleggeert-Lankamp, C.L.; Marani, E.; Thomeer, R.T.; Ottenhoff, T.H., 2000:
Allorecognition of artificial nerve guides filed with human Schwann cells: an in vitro piloot study

Amrolia, P.J.; Reid, S.D.; Gao, L.; Schultheis, B.; Dotti, G.; Brenner, M.K.; Melo, J.V.; Goldman, J.M.; Stauss, H.J., 2002:
Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity

Schuster, M.; Kocher, A.A..; John, R.; Kukuy, E.; Edwards, N.; Oz, M.; Itescu, S., 2001:
Allosensitization following left ventricular assist device (LVAD) implantation is dependent on CD40-CD40 ligand interactions

Fowler, D.H.; Breglio, J.; Nagel, G.; Hirose, C.; Gress, R.E., 1996:
Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL

Lamousé-Smith, E.; McCarthy, S.A., 1997:
Allospecific cytotoxic T cells generated from beta 2m-/- mice in primary MLC: analysis of activation requirements, specificity, and phenotype

Koyamada, N.; Ohkohchi, N.; Satomi, S.; Taguchi, Y.; Mori, S., 1993:
Allospecific suppressive effect of TcR-alpha beta +CD4-8- T cells in the livers of mice inoculated with allogeneic cells via the portal vein

McEwen, B.S., 2000:
Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity

Goldstein, D.S.; McEwen, B., 2002:
Allostasis, homeostats, and the nature of stress

Karlamangla, A.S.; Singer, B.H.; McEwen, B.S.; Rowe, J.W.; Seeman, T.E., 2002:
Allostatic load as a predictor of functional decline. MacArthur studies of successful aging

Takeuchi, M.; Shioya, T.; Swager, T.M., 2001:
Allosteric Fluoride Anion Recognition by a Doubly Strapped Porphyrin This work was funded by the Department of Energy, by a contract through Bechtel Nevada, and the Office of Naval Research. M.T. thanks the Ministry of Education, Science and Culture of Japan for financial support and Prof. Itaru Hamachi and Mr. Masato Ikeda at Kyushu University for helpful discussions

Fritsky; Ott; Krämer, 2000:
Allosteric Regulation of Artificial Phosphoesterase Activity by Metal Ions This work was funded by the DFG (Gerhard Hess Programm)

Chang, Y.; Weiss, D.S., 1999:
Allosteric activation mechanism of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine

Gao, Z.G.; Wang, L.; Liu, C.G., 1996:
Allosteric and competitive interactions of 2 alpha-(2',2'-disubstituted- hydroxy-ethoxy)tropane and its optical isomers at rat central muscarinic acetylcholine receptors

Brunner, A.; de Robichon-Szulmajster, H., 1969:
Allosteric behavior of yeast threonine deaminase under partially inactivating conditions

Sygusch, J.; Beaudry, D., 1998:
Allosteric communication in mammalian muscle aldolase

Marabotti, A.; De Biase, D.; Tramonti, A.; Bettati, S.; Mozzarelli, A., 2001:
Allosteric communication of tryptophan synthase. Functional and regulatory properties of the beta S178P mutant

Saxena; Hur; Doctor, 1999:
Allosteric control of acetylcholinesterase activity by monoclonal antibodies

Garaudée, S.; Elhabiri, M.; Kalny, D.; Robiolle, Céline.; Trendel, J-Michel.; Hueber, R.; Van Dorsselaer, A.; Albrecht, P.; Albrecht-Gary, A-Marie., 2002:
Allosteric effects in norbadione A. A clue for the accumulation process of 137Cs in mushrooms?

Colwell; Blinder; Tsiang; Gibbs; Bock; Tollefsen, 1999:
Allosteric effects of a monoclonal antibody against thrombin exosite II

Dun, W.; Jiang, M.; Tseng, G.N., 2000:
Allosteric effects of mutations in the extracellular S5-P loop on the gating and ion permeation properties of the hERG potassium channel

Mohr, K.; Tränkle, C., 1994:
Allosteric effects of the alkane-bis-ammonium compound W84 and of tacrine on [3H]pirenzepine binding at M1-receptors in rat cerebral cortex

Mihailescu, M.R.; Fronticelli, C.; Russu, I.M., 2001:
Allosteric free energy changes at the alpha 1 beta 2 interface of human hemoglobin probed by proton exchange of Trp beta 37

Pestaña, A.; Marco, R.; Sols, A., 1968:
Allosteric glutaminase in rat liver of likely regulatory significance

Blandin, V.; Vigne, P.; Breittmayer, J.P.; Frelin, C., 2000:
Allosteric inhibition of endothelin ETA receptors by 3, 5-dibromosalicylic acid

Rozengurt, E.; de Asúa, L.J..; Carminatti, H., 1970:
Allosteric inhibition of muscle pyruvate kinase by phenylalanine

Tormanen, C.D., 2002:
Allosteric inhibition of rat liver and kidney arginase by copper and mercury ions

Tanaka, H.; Walker, R.T.; Hopkins, A.L.; Ren, J.; Jones, E.Y.; Fujimoto, K.; Hayashi, M.; Miyasaka, T.; Baba, M.; Stammers, D.K.; Stuart, D.I., 1999:
Allosteric inhibitors against HIV-1 reverse transcriptase: design and synthesis of MKC-442 analogues having an omega-functionalized acyclic structure

Pruzan, R.; Pongracz, K.; Gietzen, K.; Wallweber, G.; Gryaznov, S., 2002:
Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates

Lazareno, S.; Popham, A.; Birdsall, N.J., 2000:
Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site

Perkovic, M.W., 2001:
Allosteric manipulation of photoexcited state relaxation in (bpy)2RuII(binicotinic acid)

Findlay, G.S.; Ueno, S.; Harrison, N.L.; Harris, R.A., 2000:
Allosteric modulation in spontaneously active mutant gamma-aminobutyric acid(A) receptors [corrected

Findlay, G.S.; Ueno, S.; Harrison, N.L.; Harris, R.A., 2001:
Allosteric modulation in spontaneously active mutant gamma-aminobutyric acidA receptors

Chigr, F.; M'Hamed, S.B.; Najimi, M., 2002:
Allosteric modulation of GABAA receptor by somatostatin is altered under stress in rat brainstem

Taylor, M.T.; Bonhaus, D.W., 2000:
Allosteric modulation of [(3)H]gabapentin binding by ruthenium red

Giorgi, O.; Cancedda, E.; Lecca, D.; Orlandi, M.; Corda, M.G., 1994:
Allosteric modulation of [35S]TBPS-binding in the cerebral cortex of the rat during postnatal development

Mugnaini, M.; Giberti, A.; Ratti, E.; van Amsterdam, F.T., 1993:
Allosteric modulation of [3H]CGP 39653 binding by glycine in rat brain

Slany, A.; Zezula, J.; Fuchs, K.; Sieghart, W., 1995:
Allosteric modulation of [3H]flunitrazepam binding to recombinant GABAA receptors

Swaminath, G.; Steenhuis, J.; Kobilka, B.; Lee, T.Weon., 2001:
Allosteric modulation of beta2-adrenergic receptor by Zn(2+)

DeHaven-Hudkins, D.L.; Ford-Rice, F.Y.; Allen, J.T.; Hudkins, R.L., 1993:
Allosteric modulation of ligand binding to [3H](+)pentazocine-defined sigma recognition sites by phenytoin

Maelicke, A., 2000:
Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease

Pfeiffer, S.; Gorren, A.C.; Pitters, E.; Schmidt, K.; Werner, E.R.; Mayer, B., 1998:
Allosteric modulation of rat brain nitric oxide synthase by the pterin-site enzyme inhibitor 4-aminotetrahydrobiopterin

Tang, L.H.; Aizenman, E., 1993:
Allosteric modulation of the NMDA receptor by dihydrolipoic and lipoic acid in rat cortical neurons in vitro

Boiteux, A.; Hess, B., 1970:
Allosteric properties of yeast pyruvate decarboxylase

Edelstein, S.J.; Changeux, J.P., 1996:
Allosteric proteins after thirty years: the binding and state functions of the neuronal alpha 7 nicotinic acetylcholine receptors

Changeux, J.P.; Changeux, J.P.; Monod, J., 1993:
Allosteric proteins: from regulatory enzymes to receptors--personal recollections

Birdsall, N.J.; Lazareno, S.; Matsui, H., 1996:
Allosteric regulation of muscarinic receptors

Gnagey, A.; Ellis, J., 1996:
Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptors

Hansen, S.; Hupp, T.R.; Lane, D.P., 1996:
Allosteric regulation of the thermostability and DNA binding activity of human p53 by specific interacting proteins. CRC Cell Transformation Group

Koizumi, M.; Kerr, J.N.; Soukup, G.A.; Breaker, R.R., 2000:
Allosteric ribozymes sensitive to the second messengers cAMP and cGMP

Ikeda, M.; Tanida, T.; Takeuchi, M.; Shinkai, S., 2000:
Allosteric silver(I) ion binding with peripheral pi clefts of a Ce(IV) double decker porphyrin

Buller, S.; Zlotos, D.Paul.; Mohr, K.; Ellis, J., 2001:
Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands

Iyo, M.; Kawasaki, H.; Taira, K., 2002:
Allosterically controllable maxizymes for molecular gene therapy

Chenu, C.; Berteloot, A., 1993:
Allosterism and Na(+)-D-glucose cotransport kinetics in rabbit jejunal vesicles: compatibility with mixed positive and negative cooperativities in a homo- dimeric or tetrameric structure and experimental evidence for only one transport protein involved

Saibil, H.R.; Horwich, A.L.; Fenton, W.A., 2002:
Allostery and protein substrate conformational change during GroEL/GroES-mediated protein folding

Allain, J.E.; Mahieu-Caputo, D.; Loux, N.; Dagher, I.; Di Rico, V.; Andréoletti, M.; Franco, D.; Capron, F.; Weber, A., 2001:
Allotransplantation in utero and immortalization of primate fetal hepatocytes

Cheng, X.; Zhao, T.; Li, G., 2001:
Allotransplantation of cryopreserved fetal cartilage in plastic surgery

Nagahara, K.; Wada, Y., 1994:
Allotransplantation of cryopreserved menisci in monkey: histological change

Song, C.; Song, Y.; Wu, L.; Ma, B.; Duan, X.; Pan, S.; Song, C., 2002:
Allotransplantation of cultured fetal parathyroid gland cells in treating patients with hypoparathyroidism

Wang, P.; Zhang, G.; Yang, T., 1996:
Allotransplantation of fetal adrenal capsules for treating steroid deficiency

Galibin, O.V.; Sherstnov, M.Iu.; Emanuél', V.L.; Kashchenko, V.A.; Kofman, A.V., 1996:
Allotransplantation of pancreatic islet cells and antinuclear antibodies

Dendeberov, E.S., 2001:
Allotransplantation of pituitary cells to rat testicle

Ye, J.; Wang, H.M.; Ogden, T.E.; Ryan, S.J., 1993:
Allotransplantation of rabbit retinal pigment epithelial cells double-labelled with 5-bromodeoxyuridine (BrdU) and natural pigment

Tołlłloczko, T.; Sawicki, A.; Woźniewicz, B.; Nawrot, I.; Górski, A.; Migaj, M.; Zawitkowska, T., 1995:
Allotransplantation of the parathyroid in patients without immunosuppression

Squiers, E.C.; Hodell, M.; Beulow, R., 1997:
Allotrap prolongs survival of porcine islet xenografts in diabetic mice

Fawell, J., 1996:
Allotropes versus polymorphisms

Sidwell, R.U.; Francis, N.; Roberts, N.M.; Staughton, R.C.D., 2002:
Allotropic cutaneous amyloidosis: coincidence or progression?

Pan, Q.; Rabbani, H.; Mills, F.C.; Severinson, E.; Hammarström, L., 1997:
Allotype-associated variation in the human gamma3 switch region as a basis for differences in IgG3 production

Döring, G.; Krogh-Johansen, H.; Weidinger, S.; Høiby, N., 1994:
Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508

Ad'Hiah, A.H.; Mitchell, J.; Papiha, S.S., 1996:
Allotypes of complement components C4, C3, C2 and BF in the populations of Tasmania and northeast England

Würzner, R., 2000:
Allotyping of complement components

Lindqvist, B., 1997:
Allow competition in our country's health care

Schwenker, G., 1997:
Allow me some remarks on the views of the future in issue 6/96 pages 298-300

Redling, R., 2002:
Allow options, not variations, in EMR use. A multispecialty group's experience with electronic medical records

Murphy, P.A., 1993:
Allow the nurses

Dunne, R.F., 1994:
Allowable business expenses

Adilov, V.B.; Gusarov, I.I.; Dubovskoĭ, A.V.; Petrova, N.G.; Belenichev, A.Iu.; Trebukhov, I.A., 2001:
Allowable concentration of radionuclide in mineral water, therapeutic mud and clay

Baĭko, V.G.; Skurikhin, I.M., 1996:
Allowable fluctuations in the data on the content of lipid-complex components in food products in chemical composition tables

Hunter, M.F.; Heaf, D.P., 1993:
Allowances for care for children with cystic fibrosis

Fang; Persson; Cohen, 1988:
Allowed 3h-1e transition in semiconductor quantum wells

Deza, M.; Fowler, P.W.; Grishukhin, V., 2001:
Allowed boundary sequences for fused polycyclic patches and related algorithmic problems

Meissner; Hild; Kunze; Schmidt-Ott; Wennemann; Sood; Kirchner; Roeckl; Rykaczewski, 1995:
Allowed-unhindered beta decay of 180Yb and the nuclear structure of 180Lu

Ketterer, E.M., 2002:
Allowing a part of the ego to die as well

Pierce, S.F., 1999:
Allowing and assisting patients to die: the perspectives of oncology practitioners

Arendt, R., 1989:
Allowing death or actively killing? The legal situation and present state of ethical debate in the Nordic countries

George, S., 1992:
Allowing employees to pick the one "that's good for you"

Walker, D.; Kumaranayake, L., 2002:
Allowing for differential timing in cost analyses: discounting and annualization

Berestovskiĭ, G.N.; Ternovskiĭ, V.I.; Kataev, A.A., 2000:
Allowing for polymer polydispersity--an essential condition for determination of aqueous pore diameters in cell walls and membranes using polymers

Walker, D.; Fox-Rushby, J., 2001:
Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis

Love, S.H., 1993:
Allowing new technology to erode constitutional protections: a Fourth Amendment challenge to non-consensual DNA testing of prisoners

Franklin, C., 1993:
Allowing patients to decide

McLauchlan, C.A., 1997:
Allowing relatives to witness resuscitation

Breslan, A.J., 1994:
Allowing severely burned patients to make the choice to die is not unique

Rosenbaum, S.; Borzi, P.C.; Smith, V., 2001:
Allowing small businesses and the self-employed to buy health care coverage through public programs

Pownall, M., 1986:
Allowing surgeons time to think

Jarman, H.; Jacobs, E.; Walter, R.; Witney, C.; Zielinski, V., 2002:
Allowing the patients to sleep: flexible medication times in an acute hospital

Zimmerman, A., 1991:
Allowing the unconscious to depart

McLetchie, N.G.; Dunn, J.Shaw.; McLetchie, N., 2002:
Alloxan diabetes: a discovery, albeit a minor one

Szkudelski, T.; Kandulska, K.; Okulicz, M., 1999:
Alloxan in vivo does not only exert deleterious effects on pancreatic B cells

Balog, Z.; Klepac, R.; Rosić, S.; Jukić-Lesina, T., 2002:
Alloxan induced cataract in a rat

Kliber, A.; Szkudelski, T.; Chichłowska, J., 1996:
Alloxan stimulation and subsequent inhibition of insulin release from in situ perfused rat pancreas

Ford; Myles; Shen, 1985:
Alloy broadening of impurity electronic spectra: One-dimensional-model calculations for a ternary alloy

Ford; Myles, 1988:
Alloy broadening of the deep electronic levels associated with the As vacancy in AlxGa

Ekpenuma; Myles; Gregg, 1990:
Alloy disorder effects on the electronic properties of III-V quaternary semiconductor alloys

Bertho; Jouanin, 1993:
Alloy effects on the band offsets of ZnSxSe1-x-ZnSe heterostructures

Mikkelsen, Ø.; Schrøder, K.H., 2001:
Alloy electrodes with high hydrogen overvoltage for analytical use in voltammetry. Some preliminary results

Johnson, 1989:
Alloy models with the embedded-atom method

Chattopadhyay, 1985:
Alloy scattering in quantum-well structures of semiconductor ternaries

Haug, 1994:
Alloy-assisted Auger recombination in ternary III-V compounds

Kalt; Rühle; Reimann; Rinker; Bauser, 1991:
Alloy-disorder-induced intervalley coupling

Ray; Basu, 1992:
Alloy-disorder-scattering-limited mobility of electrons in a superlattice

Lyo; Fritz, 1992:
Alloy-scattering and strain-fluctuation-scattering contributions to the low-temperature electron mobility in ternary quantum wells and heterostructures

Wei; Zunger, 1986:
Alloy-stabilized semiconducting and magnetic zinc-blende phase of MnTe

Schmid, A.K.; Bartelt, N.C.; Hwang, R.Q., 2000:
Alloying at surfaces by the migration of reactive two-dimensional islands

Bhuinya; Padhi, 1993:
Alloying effect on K beta -to-K alpha intensity ratios in TixNi1-x and CrxNi1-x alloys studied by gamma -ray fluorescence and fast proton ionization

Li; Xu; Chen; Xiao, 1994:
Alloying effects of Kondo insulators

Dekker, J.P.; Volkert, C.A.; Arzt, E.; Gumbsch, P., 2001:
Alloying effects on electromigration mass transport

Wataha, J.C., 2002:
Alloys for prosthodontic restorations

Rodríguez, D.; Correa, F.; de la Rosa-Vélez, J.; Escobar, R.; Cordero, B.; Alvarez, Z.; Sánchez, R., 2002:
Allozymatic variation in crustacea Artemia franciscana (Anostraca: Artemiidae) of Freat Salt Lake in different experimental conditions

Foley, D.H.; Paru, R.; Dagoro, H.; Bryan, J.H., 1993:
Allozyme analysis reveals six species within the Anopheles punctulatus complex of mosquitoes in Papua New Guinea

van der Bank, F.H.; Engelbrecht, G.D.; Sauer-Gürth, H.; Wink, M.; Mulder, P.F., 1998 :
Allozyme and DNA sequence data support speciation of northern and southern populations of silver catfish, Schilbe intermedius (Rüppel, 1832)

Paggi, L.; Mattiucci, S.; D'Amelio, S., 2002:
Allozyme and PCR-RFLP markers in anisakid nematodes, aethiological agents of human anisakidosis

Frisman, L.V.; Korablev, V.P.; Liapunova, E.A.; Vorontsov, N.N.; Brandler, O.V., 1999:
Allozyme differentiation of various chromosomal forms of the spotted suslik (Spermophilus suslicus Guld, 1770, Rodentia)

Charlesworth, D.; Yang, Z., 1998:
Allozyme diversity in Leavenworthia populations with different inbreeding levels

Batista, F.; Sosa, P.A., 2002:
Allozyme diversity in natural populations of Viola palmensis Webb & Berth. (Violaceae) from La Palma (Canary Islands): implications for conservation genetics

Krafsur, E.S., 2000:
Allozyme gene diversities in some leaf beetles (Coleoptera: Chrysomelidae)

Hoshizaki, S., 1998:
Allozyme polymorphism and geographic variation in the small brown planthopper, Laodelphax striatellus (Homoptera: Delphacidae)

Engelhorn, R.; Schreiber, A., 1997:
Allozyme polymorphisms and biochemical-genetic taxon markers in lampreys (Lampetra, Eudontomyzon, Petromyzon)

Pavlov, S.D., 2000:
Allozyme variability and genetic divergence of Pacific trout (species Parasalmo) from western Kamchatka

Milishnikov, A.N.; Likhnova, O.P.; Nikonova, O.A.; Lavrov, V.L.; Orlov, V.N., 1994:
Allozyme variability of the European bean Castor fiber 1758 (Castoridae, Rodentia) from the Voronezh State Nature Reserve

Dangasuk, O.G.; Gudu, S., 2001:
Allozyme variation in 16 natural populations of Faidherbia albida (Del.) A. Chev

Coetzee, E.M.; Van Der Bank, F.H.; Critser, J.K., 1993:
Allozyme variation in a wild African elephant (Loxodonta africana) population from the Kruger National Park, South Africa

Zasypkin, M.Iu., 1998:
Allozyme variation in the sea otter (Enhydra lutris L. 1758). Analysis of materials from animals that died on Bering Island in the winter of 1992/1993

Mezhzherin, S.V., 1999:
Allozyme variation of lactate dehydrogenase (EC1.1.1.27) in a series of vertebrate animals

Kuz'min, E.V., 2002:
Allozyme variation of nonspecific esterases in Russian sturgeon (Acipenser güldenstädti Brandt

Fu, J.; MacCulloch, R.D.; Murphy, R.W.; Darevsky, I.S.; Tuniyev, B.S., 2001:
Allozyme variation patterns and multiple hybridization origins: clonal variation among four sibling parthenogenetic Caucasian rock lizards

N'zobadila, G.; Cabaret, J.; Gasnier, N., 1993:
Allozyme variations between sheep or rabbit laboratory reared and goat wild populations of Trichostrongylus colubriformis

Zhang, Y.; Davis, G.M.; Liu, H.X.; Feng, T., 2003:
Allozyme-based genetic variation within an unstable "population" of Chinese Oncomelania hupensis (Gastropoda: Rissoacea: Pomatiopsidae)

Smith, M.B.; Allport, G.W.; Lewin, K.; Murray, H.A., 1971:
Allport, Murray, and Lewin on personality theory: Notes on a confrontation

Morrissey, J., 1993:
Alltel acquiring TDS for $80 million

Jaklevic, M.C., 1999:
Alluring offers. DMC claims rival used excessive pay to steal docs

Noguera Palau, J.J.; Gullstrand, A., 2001:
Allvar Gullstrand. Landskrona (Sweden), 1862 - Stockholm (Sweden), 1930

Ball-Rokeach, S.J.; Loges, W.E., 2001:
Ally or adversary? Using media systems for public health

Finer, D.; Tomson, G.; Björkman, N.M., 1997:
Ally, advocate, analyst, agenda-setter? Positions and perceptions of Swedish medical journalists

McBrayer, T., 1995:
Allying with suppliers to improve quality and reduce costs

Shoji, S.; Furuishi, K.; Yanase, R.; Miyazaka, T.; Kino, M., 1993:
Allyl compounds selectively killed human immunodeficiency virus (type 1)-infected cells

Manoharan, M.; Lu, Y.; Casper, M.D.; Just, G., 2000:
Allyl group as a protecting group for internucleotide phosphate and thiophosphate linkages in oligonucleotide synthesis: facile oxidation and deprotection conditions

Musk, S.R.; Johnson, I.T., 1993:
Allyl isothiocyanate is selectively toxic to transformed cells of the human colorectal tumour line HT29

Knowles, L.M.; Milner, J.A., 2001:
Allyl sulfides modify cell growth

Chuard, R.; Giraud, A.; Renaud, P., 2002:
Allyl sulfoxides as precursors for radical two-carbon ring expansion of cyclobutanones

Chiari, M.; Cretich, M.; Crini, G.; Janus, L.; Morcellet, M., 2000:
Allylamine-beta-cyclodextrin copolymer. A novel chiral selector for capillary electrophoresis

Zhao, H.; Hans, S.; Cheng, X.; Mootoo, D.R., 2001:
Allylated monosaccharides as precursors in triple reductive amination strategies: synthesis of castanospermine and swainsonine

Yasuda, M.; Fujibayashi, T.; Baba, A., 2001:
Allylation of Carbonyl Compounds Bearing a Hydroxyl Group by Tetraallyltin: Highly Stereoselective Allylation in a Chelation-Controlled Manner

Le Serre, Séphanie.; Guillemin, J-Claude.; Karpati, Tás.; Soos, László.; Nyulászi, László.; Veszprémi, Tás., 2001:
Allylation of Phosphorus, Arsenic, and Antimony Trihalides by Allylic Stannanes. Synthesis, Spectroscopic Characterization, and Quantum Chemical Investigations of Allylic Phosphines, Arsines, and Stibines

Fujiwara, N.; Yamamoto, Y., 1997:
Allylation of Unactivated and/or Functionalized Alkynes with Allylindiums

Marcantoni, E.; Mecozzi, T.; Petrini, M., 2002:
Allylation of exocyclic N-Acyliminium ions generated from chiral N-[1-(phenylsulfonyl)alkyl]oxazolidin-2-ones

Linhart, L.; Roztocil, A.; Pilka, D., 1993:
Allylestrenol (Gestormon) in the treatment of threatened abortion

Johannsen, M.; Jørgensen, K.Anker., 2002:
Allylic Amination

Overman, L.E..; Zipp, G..Greg., 1997:
Allylic Transposition of Alcohol and Amine Functionality by Thermal or Palladium(II)-Catalyzed Rearrangements of Allylic N-Benzoylbenzimidates

Di Valentin, C.; Gandolfi, R.; Gisdakis, P.; Rösch, N., 2001:
Allylic alcohol epoxidation by methyltrioxorhenium: a density functional study on the mechanism and the role of hydrogen bonding

Cheng, D.; Kreethadumrongdat, T.; Cohen, T., 2001:
Allylic lithium oxyanionic directed and facilitated simmons-smith cyclopropanation: stereoselective synthesis of (+/-)-cis-sabinene hydrate and a novel ring expansion

Jiménez-Estrada, M.; García, M.O.; Navarro, A.O.; Eusebio, J.L.; Alvarez, C.T.; Penieres, G.C.; Gutiérrez, R.P., 1997:
Allylic nitration of 3 beta-sitosterol and cholesterol acetate: preparation of 7-nitro derivatives

Lobben, P.C..; Paquette, L.A.., 2001:
Allylindation of 6-Substituted 2-Hydroxy-1-tetralones in Aqueous and Organic Media. Stereochemistry and Competition Studies

Araki, S.; Shiraki, F.; Tanaka, T.; Nakano, H.; Subburaj, K.; Hirashita, T.; Yamamura, H.; Kawai, M., 2001:
Allylindation of cyclopropenes in organic and aqueous media: switching the regio- and stereoselectivity based on the chelation with a hydroxyl group and the crystal structure of the cyclopropylindium product

Zou, W.; Abraham, M.; Gilbert, M.; Wakarchuk, W.W.; Jennings, H.J., 2000:
Allylmalonamide as a bivalent linker: synthesis of biantennary GM3-saccharide--keyhole limpet hemocyanin glycoconjugate and the immune response in mice

de Rooij, B.M.; Boogaard, P.J.; Commandeur, J.N.; van Sittert, N.J.; Vermeulen, N.P., 1998:
Allylmercapturic acid as urinary biomarker of human exposure to allyl chloride

Tanii, H.; Zang, X.P.; Saijoh, K., 1999 :
Allylnitrile-induced behavioral abnormalities and findings relating to the mechanism underlying behavioral abnormalities

Miura, K.; Saito, H.; Nakagawa, T.; Hondo, T.; Tateiwa Ji, J-ichi.; Sonoda, M.; Hosomi, A., 2001:
Allylsilylation of Carbon-Carbon and Carbon-Oxygen Unsaturated Bonds via a Radical Process(1)

Miura, K.; Saito, H.; Itoh, D.; Matsuda, T.; Fujisawa, N.; Wang, D.; Hosomi, A., 2001:
Allylstannylation of carbon-carbon and carbon-oxygen unsaturated bonds via a radical chain process

Avato, P.; Tursil, E.; Vitali, C.; Miccolis, V.; Candido, V., 2001:
Allylsulfide constituents of garlic volatile oil as antimicrobial agents

Oi, Y.; Shishido, C.; Wada, K.; Odaka, H.; Ikeda, H.; Iwai, K., 2000:
Allylthiamindisulfide and related compounds enhance thermogenesis with increasing noradrenaline and adrenaline secretion in rats

Szymoniak, J.; Lefranc, Hé.; Moïse, C., 1996:
Allyltitanation-Mukaiyama Aldol Sequence: A Short Way To Control Five Stereogenic Carbon Centers

Anonymous, 1993:
Alma Ata revisited

Solomon, M.P.; Granick, M.S.; Morani, A.D., 1997:
Alma Dea Morani, MD: a pioneer in plastic surgery

Venediktov, D., 1998:
Alma-Ata and after

Fenton, M.V., 1994:
Alma-Ata, at last

Blanche, E.I., 1996 :
Alma: coping with culture, poverty, and disability

Fend, F., 1998:
Almarsi NM, Zaer FS, Iturraspe JA, Braylan RC. Contribution of flow cytometry to the diagnosis of gastric lymphomas in endoscopic biopsy specimens. Mod Pathol 1997;10:650-6

Haldeman, S.; Haldeman, A.J., 1983:
Almeda Haldeman, Canada's first chiropractor: pioneering the prairie provinces, 1907-1917

Pers, M., 1994:
Almindeligt Hospital -- a large and considerable building

Köhler, D.; Criée, C.; Raschke, F., 1998:
Almitrin and patients with COPD--a dangerous combination?

Puybasset, L.; Rouby, J.J., 2000:
Almitrine and NO in acute respiratory distress syndrome: two pieces of the same puzzle?

González-Ruiz, J.M., 1993:
Almitrine bismesylate in chronic obstructive pulmonary disease

Payen, D.M.; Gatecel, C.; Plaisance, P., 1993:
Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome

Nowak, D.; Wywiol, A.; Magnussen, H., 1998:
Almitrine in therapy of chronic obstructive respiratory tract diseases with hypoxemia--a clinical multicenter study comparing 2 dosages

Copin, J.C.; Ledig, M.; Tholey, G., 1993:
Almitrine prevents some hypoxia-induced metabolic injury in rat astrocytes

Malone, R.E., 1996 :
Almost 'like family': emergency nurses and 'frequent flyers'

Martin, S., 2001:
Almost 1 in 2 Canadians says health system needs major surgery

Spear, H.J., 2002:
Almost 20 years after a traumatic birth experience: "Joshua is doing just fine"

Anonymous, 1999:
Almost 3% of men report non-consensual sexual experiences as adults

Saunders, D.I.; Meek, T., 2001:
Almost 30% of anaesthetic machines in UK do not have anti-hypoxia device

Håkansson, A.; Andersson, D.; Hagander, B.; Lindholm, L.; Nerbrand, C.; Svärdsudd, K.; Törnqvist, M., 1994:
Almost 400 physicians were denied to practice family medicine. 70 percent must complete their education

Anonymous, 2001:
Almost 500,000 to lose M+C

Anonymous, 2000:
Almost 6,000 double-infected patients in Germany. Hepatitis C burden in HIV patients

Bergman, R., 1999:
Almost 80. Aged population: expectations and roles

Anonymous, 1995:
Almost 9 in 10 maternal deaths could be prevented, Zimbabwe study shows

Ross, B.M., 1999:
Almost a fountain of youth. The politicians ignore medical marvels that will cut the costs of Medicare

Appelbaum, P.S., 1997:
Almost a revolution: an international perspective on the law of involuntary commitment

Kittrell, A., 1985:
Almost all workers have health cover: study

Taniguchi; Nakamura, 2000:
Almost analytic solutions to equilibrium sequences of irrotational binary polytropic stars for n = 1

Lloyd, 1995:
Almost any quantum logic gate is universal

Bohlen, C., 1995:
Almost anything goes in birth science in Italy

Atasua, M.; Dumlu, A.; Ozbayrak, S., 2001:
Almost complete absence of the scalp and body hair in association with oligodontia and zygodactylous palmar triradii

Hiranuma, T.; Iwao, K.; Kitamura, K.; Matsumiya, T.; Oka, T., 1997:
Almost complete protection from [Met5]-enkephalin-Arg6-Gly7-Leu8 (Met-enk-RGL) hydrolysis in membrane preparations by the combination of amastatin, captopril and phosphoramidon

Faetti; Gatti; Palleschi; Sluckin, 1985:
Almost critical behavior of the anchoring energy at the interface between a nematic liquid crystal and a SiO substrate

Francis, G.S., 2002:
Almost daily I have read about advances in genetics. Will this translate into better treatments for heart disease?

Blackmon, G.A., 2000:
Almost doesn't count

Linden, N.; Popescu, S.; Wootters, W.K., 2002:
Almost every pure state of three qubits is completely determined by its two-particle reduced density matrices

Anonymous, 1983:
Almost everything you need to know about HMOs but haven't had time to think about

Gold, E., 1996:
Almost extinct diseases: measles, mumps, rubella, and pertussis

Solovy, A., 2002:
Almost famous

Wright, J.R.; Noble, E.Clark., 2002:
Almost famous: E. Clark Noble, the common thread in the discovery of insulin and vinblastine

Plug, C., 1992:
Almost forgotten, never told: the Griqualand West Medical Society (1882)

Cho, M.H.; Tantisira, K.G., 2018:
Adrenal insufficiency and ICS: genetics takes a breath

Anonymous, 2000:
Almost half of Americans report suicide attempt by close friend or relative

Anonymous, 2000:
Almost half of adults with a head injury suffer long term disability

Porter, S., 1990:
Almost home

Anonymous, 1999:
Almost invariably

Bartlett; Maiorov; Meir, 1998:
Almost linear VC-dimension bounds for piecewise polynomial networks

Smith, R., 2001:
Almost no evidence exists that the internet harms health

Schonfeld, D.J., 2002:
Almost one year later: looking back and looking ahead

Pauly, M.V., 1995:
Almost optimal social insurance for long-term care

Childress, J.F.; Shapiro, H.T., 1999:
Almost persuaded: reactions to Oldham et al

Zumbach, 1993:
Almost second order phase transitions

Vastag, B., 2000:
Almost serendipity: alcoholism drug reverses drug resistance in vitro

Berry, T.G.; Nicholson, J.; Troendle, K., 1994:
Almost two centuries with amalgam: where are we today?

Bender; Boettcher; Lipatov, 1992:
Almost zero-dimensional quantum field theories

Turok, 1996:
Almost-Goldstone bosons from extra-dimensional gauge theories

Spaek; Gopalan, 1990:
Almost-localized electrons in a magnetic field

Starkman, 1992:
Almost-standard big-bang nucleosynthesis with Omega Bh20 >> 0.015: A reexamination of neutrino chemical potentials and Delta G

Rienks, A., 2001:
Almost-tolerance halves cyclosporine dose

Anonymous, 2002:
Almotriptan (Axert) and frovatriptan (Frova) for migrane

Anonymous, 2001:
Almotriptan joins migraine market

Mannix, L.K.; Adelman, J.U.; Goldfarb, S.D.; Von, S.; Kozma, C.M., 2002:
Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms

Gras, J.; Llenas, Jús.; Jansat, J.M.; Jáuregui, Jé.; Cabarrocas, X.; Palacios, Jé.M., 2002:
Almotriptan, a new anti-migraine agent: a review

Cull, R., 2001:
Almotriptan: a balanced approach to migraine

Von, S., 2002:
Almotriptan: a review of pharmacology, clinical efficacy, and tolerability

Pascual, J., 2002:
Almotriptan: pharmacological differences and clinical results

Worboys, M.; Wright, A., 2000:
Almroth Wright at Netley: modern medicine and the military in Britain, 1892-1902

Matthews, J.Rosser.; Wright, A., 2002:
Almroth Wright, vaccine therapy, and British biometrics: disciplinary expertise versus statistical objectivity

Turk, J.L.; Wright, A., 1994:
Almroth Wright--phagocytosis and opsonization

Wagner, L.L.; Bessarab, D.A.; Kopantzev, E.P.; Borodin, A.M., 1993:
Aln1 and Aln5--new oligonucleotide primers for Alu-PCR analysis of human DNA

Goldstein, J.; Dahlöf, C.G.; Diener, H.C.; Olesen, J.; Schellens, R.; Senard, J.M.; Simard, D.; Steiner, T.J., 1996:
Alniditan in the acute treatment of migraine attacks: a subcutaneous dose-finding study. Subcutaneous Alniditan Study Group

Leysen, J.E.; Gommeren, W.; Heylen, L.; Luyten, W.H.; Van de Weyer, I.; Vanhoenacker, P.; Haegeman, G.; Schotte, A.; Van Gompel, P.; Wouters, R.; Lesage, A.S., 1996:
Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan

Blaas, H.G.; Eik-Nes, S.H.; Vainio, T.; Isaksen, C.V., 2000:
Alobar holoprosencephaly at 9 weeks gestational age visualized by two- and three-dimensional ultrasound

Takahashi, S.; Miyamoto, A.; Oki, J.; Saino, T.; Inyaku, F., 1995:
Alobar holoprosencephaly with diabetes insipidus and neuronal migration disorder

Weiss, H.; Scherthan, H., 2002:
Aloe spp.--plants with vertebrate-like telomeric sequences

Reynolds, T.; Dweck, A.C., 2000:
Aloe vera leaf gel: a review update

Vogler, B.K.; Ernst, E., 2000:
Aloe vera: a systematic review of its clinical effectiveness

Atherton, P., 1998:
Aloe vera: magic or medicine?

Choi, S.; Lee, S-K.; Kim, J-E.; Chung, M-H.; Park, Y-I., 2002:
Aloesin inhibits hyperpigmentation induced by UV radiation

Kircher, T.; Wormstall, H.; Alzheimer, A., 1997:
Alois Alzheimer (1864-1915)--student days and first scientific activities

Brannon, W.L.; Alzheimer, A., 1994:
Alois Alzheimer (1864-1915). I. Contributions to neurology and psychiatry

Brannon, W.L.; Alzheimer, A., 1994:
Alois Alzheimer (1864-1915). II. Dementia before and after Alzheimer: a brief history

Kiejna, A.; Górna, R.; Alzheimer, A., 1998:
Alois Alzheimer's traces in Wrocław

Devi, G.; Quitschke, W.; Alzheimer, A., 1999:
Alois Alzheimer, neuroscientist (1864-1915)

Nemes, C.N.; Martin, A., 1994:
Alois Martin, pioneer of surgical anesthesia in Germany. Contribution to the history of inhalation anesthesia in the general newspaper Spiegel der Augsburger in 1847. I

Maĭchuk, I.F.; Khaitova, K.N.; Grishakova, M.B., 1998:
Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis

Krásný, J., 1998:
Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy

Agnew, T., 1997:
Alone again or...

Saffioti, H.I., 1995:
Alone at last: Brazil on the road to Beijing

Olunloyo, S., 1993:
Alone in Kano

Tremethick, M.J., 2002:
Alone in a crowd. A study of social networks in home health and assisted living

Fjordbo, M., 1993:
Alone in the legal system

Klein, J.; Klein, J., 1994:
Alone on the heart of the earth: an immunogeneticist's journey into the past

Faessen, W.B., 1988:
Alone or with other persons at an address

Landro, L., 1999:
Alone together. Cancer patients and survivors find treatment--and support--online. It can make all the difference

Broaddus, B.; Lerner, A., 2001:
Alone together: managing history of medicine collections in non-historical environments (Part II)

Molofsky, M., 2002:
Aloneness with aesthetic pleasure: a developmental step reflected in memory and dream

Daul, C.B.; Antonetti, L.B., 2001:
Along came an allergen--the science of aerobiology

Belisle, L., 2000:
Along for the ride

Oken, E.; Lightdale, J.R.; Welty, T.K., 1995:
Along for the ride: the prevalence of motor vehicle passengers riding with drivers who have been drinking in an American Indian population

Mangham, C.; Viscount, P.W., 1997:
Along the boardwalk: effects of a boardwalk on walking behaviour within a Nova Scotia community

Lloyd, D.H.; Cerundolo, R., 2001:
Alopecia X in dogs

Sinke, J.D., 1996:
Alopecia above the tail base in cats

Tomás, S.; Montserrat, M.; Segarra, M.; Casademont, J., 1993:
Alopecia and albendazole

Kasperlik-Zaluska, A.A.; Godziejewska, M., 2000:
Alopecia and cardiovascular events

Barbato, M.; Viola, F.; Grillo, R.; Franchin, L.; Lo Russo, L.; Lucarelli, S.; Frediani, T.; Mazzilli, M.C.; Cardi, E., 1999:
Alopecia and coeliac disease: report of two patients showing response to gluten-free diet

Barnes, C.; Deidun, D.; Hynes, K.; Monagle, P., 2000:
Alopecia and dalteparin: a previously unreported association

Wolff, H.; Kunte, C., 2002:
Alopecia and hirsutism. Grief with beautiful hair

McKinney, P.A.; Finkenbine, R.D.; DeVane, C.L., 1996:
Alopecia and mood stabilizer therapy

Twersky, J.M.; Sheth, A.P.; Lucky, A.W., 2002:
Alopecia and red, scaly skin in a newborn

Har-Shai, Y.; Hirshowitz, B., 1996:
Alopecia and sure-closure

Friedli, A.; Harms, M., 2002:
Alopecia areata

McElwee, K.J.; Hoffmann, R., 2002:
Alopecia areata - animal models

Tebbe, B.; Gollnick, H.; Müller, R.; Reupke, H.J.; Orfanos, C.E., 1993:
Alopecia areata and diffuse hypotrichosis associated with Ullrich-Turner syndrome. Presentation of 4 patients

Lammintausta, K.; Havu, V.K., 1997:
Alopecia areata and its treatment

Smyth, J.R.; McNeil, M., 2000:
Alopecia areata and universalis in the Smyth chicken model for spontaneous autoimmune vitiligo

Cook, D.; Georgouras, K., 1993:
Alopecia areata associated with Legionnaires' disease

Kubota, T.; Ishikura, T.; Jibiki, I., 1994:
Alopecia areata associated with haloperidol

Kamada, N.; Hatamochi, A.; Shinkai, H., 1998:
Alopecia areata associated with myasthenia gravis and thymoma: a case of alopecia with marked improvement following thymectomy and high level prednisolone administration

Daly, T.J., 1998:
Alopecia areata has low plasma levels of the vasodilator/immunomodulator calcitonin gene-related peptide

Dyall-Smith, D., 1996:
Alopecia areata in a renal transplant recipient on cyclosporin

Nanda, A.; Al-Fouzan, A.S.; Al-Hasawi, F., 2002:
Alopecia areata in children: a clinical profile

de Andrade, M.; Jackow, C.M.; Dahm, N.; Hordinsky, M.; Reveille, J.D.; Duvic, M., 2000:
Alopecia areata in families: association with the HLA locus

Crowder, J.Anne.; Frieden, I.J.; Price, V.H., 2002:
Alopecia areata in infants and newborns

Olsen, E.; Hordinsky, M.; McDonald-Hull, S.; Price, V.; Roberts, J.; Shapiro, J.; Stenn, K., 1999:
Alopecia areata investigational assessment guidelines. National Alopecia Areata Foundation

Gilhar, A.; Shalaginov, R.; Assy, B.; Serafimovich, S.; Kalish, R.S., 2000:
Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice

Roger, D.; Charmes, J.P.; Bonnetblanc, J.M., 1994:
Alopecia areata occurring in a patient receiving systemic cyclosporin A

McMillen, R.; Duvic, M., 2001:
Alopecia areata occurring in sisters after administration of rifampicin

Gil Montoya, Jé.Antonio.; Cutando Soriano, A.; Jimenez Prat, Jé., 2002:
Alopecia areata of dental origin

Koblenzer, P.J., 2002:
Alopecia areata of the eyelashes

Michalowski, R., 2000:
Alopecia areata totalis/universalis and systemic corticosteroids

LaRow, J.A.; Mysliborski, J.; Rappaport, I.P.; Rouleau, G.A.; Carlson, J.A., 2001:
Alopecia areata universalis in an infant

McElwee, K.J.; Boggess, D.; King, L.E.; Sundberg, J.P., 1999:
Alopecia areata versus juvenile alopecia in C3H/HeJ mice: tools to dissect the role of inflammation in focal alopecia

Nunez, J.; Grande, K.; Hsu, S., 2000:
Alopecia areata with features of loose anagen hair

Epstein, E., 1993:
Alopecia areata, topical minoxidil, and balanced reviews

Shapiro, J.; Sundberg, J.P.; Bissonnette, R.; McElwee, K.J.; McLean, D.I.; Carroll, J.M.; Oliver, R.F.; Tang, L.; Lui, H., 2000:
Alopecia areata-like hair loss in C3H/HeJ mice and DEBR rats can be reversed using topical diphencyprone

Hoffmann, R.; Happle, R., 1999:
Alopecia areata. 1: Clinical aspects, etiology, pathogenesis

Bertolino, A.P., 2000:
Alopecia areata. A clinical overview

Fanti, P.A.; Tosti, A.; Bardazzi, F.; Guerra, L.; Morelli, R.; Cameli, N., 1994:
Alopecia areata. A pathological study of nonresponder patients

Paukstadt, W., 2001:
Alopecia areata. Only an inflammation can still help

Hoffmann, R.; Happle, R., 1999:
Alopecia areata. Part 2: Therapy

Papadopoulos, A.J.; Schwartz, R.A.; Janniger, C.K., 2001:
Alopecia areata. Pathogenesis, diagnosis, and therapy

McElwee, K.J.; Tobin, D.J.; Bystryn, J.C.; King, L.E.; Sundberg, J.P., 1999:
Alopecia areata: an autoimmune disease?

Verraes, S.; Vereecken, P., 1998:
Alopecia areata: diagnostic and therapeutic approach

MacDonald, N., 2000:
Alopecia areata: identification and current treatment approaches

Bernard, P.; Arnoult-Coudoux, E., 2001:
Alopecia areata: management strategy

Sehgal, V.N.; Jain, S., 2002:
Alopecia areata: past perceptions

MacDonald, N.; Wiseman, M.C.; Shapiro, J., 2002:
Alopecia areata: topical immunotherapy--application and practical problems

Assouly, P., 2002:
Alopecia areata: update on therapy

Hordinsky, M.K., 2001:
Alopecia areatia: pathophysiology and latest developments

Talbot, D.; Rix, D.; Abusin, K.; Mirza, D.; Manas, D., 1998:
Alopecia as a consequence of tacrolimus therapy in renal transplantation?

Weinroth, S.E.; Tuazon, C.U., 1993:
Alopecia associated with fluconazole treatment

Picard, C.; Jonville-Bera, A.P.; Billard, C.; Autret, E., 1997:
Alopecia associated with gabapentin: first case

Bouscarat, F.; Prevot, M.H.; Matheron, S., 1999:
Alopecia associated with indinavir therapy

Daghfous, R.; Ben Amor, S.; Loueslati, M.H.; El Aidli, S.; Srairi, S.; Lakhal, M.; Sebai, S.; Khaldi, M.; Belkahia, C., 1995:
Alopecia caused by nimodipine

Finley, E.M.; Ertle, J.O.; Marschall, S.F., 1994:
Alopecia in a 19-month-old boy. Monilethrix

Jonides, L., 1995:
Alopecia in an adolescent

Al-Fouzan, A.S.; Nanda, A., 2001:
Alopecia in children

Ben-Amitai, D.; Garty, B.Z., 1993:
Alopecia in children after cardiac surgery

Cosgrove, J.F., 2000:
Alopecia in the operating theatre: what are the bald facts?

Whitwam, W.; Lewis, M.; Rabb, H., 2001:
Alopecia in three women of Southeast Asian descent with chronic renal failure: possible association with erythropoietin use

Radmanesh, M.; Mousavipour, M., 2000:
Alopecia induced by ants

Kagoura, M.; Morohashi, M., 2000:
Alopecia mice derived from albino ddY mice: breeding, histological and ultrastructural studies

Anderson, B.E.; Mackley, C.L.; Helm, K.F., 2002:
Alopecia mucinosa: report of a case and review

Mallon, E.; Dawber, R.P., 1994:
Alopecia neoplastica without alopecia: a unique presentation of breast carcinoma scalp metastasis

Runne, U., 1993:
Alopecia psoriatica. Characteristics of an up to now neglected disease picture

Aroca García, M.D.; Luna Rodríguez, C.; Gallego Navarro, M.A.; Ortiz de Solar, E., 1997:
Alopecia secondary to tenoxicam. An undescribed adverse effect?

FitzGerald, J.M.; Turner, M.T.; Dean, S.; Elwood, R.K., 1996:
Alopecia side-effect of antituberculosis drugs

Strasser, S.; Lucas, M., 1993:
Alopecia triangularis congenita. Clinical manifestations--surgical correction with autologous hair transplantation

Feher, O.; Sant'Ana, R.Oliveira.; Valadares, A.Domingues.; Anelli, A., 2002:
Alopecia universalis completely resolved following autologous bone marrow transplantation

El-Shanti, H.; Ahmad, M.; Ajlouni, K., 2002:
Alopecia universalis congenita, XY gonadal dysgenesis and laryngomalacia: a novel malformation syndrome

Chaudhuri, S.; Basu, K.; Dhar, M.C.; Das, S.; Chatterjee, G.; Banerjee, G.; Mitra, K., 2002:
Alopecia universalis in a case of systemic lupus erythematosus

Kiliç, S.; Ersoy, F.; Sanal, O.; Türkbay, D.; Tezcan, I., 1999:
Alopecia universalis in a patient with common variable immunodeficiency

Ikeda, A.; Shibasaki, H.; Shiozaki, A.; Kimura, J., 1997:
Alopecia with carbamazepine in two patients with focal seizures

Gumbrell, R.C.; Rest, J.R.; Taylor, R.W., 1998:
Alopecia with follicular dystrophy in a cow

Zalka, A.D.; Byarlay, J.A.; Goldsmith, L.A., 1994:
Alopecia à deux: simultaneous occurrence of alopecia in a husband and wife

Hoefer, H.F.; Chen, S-Hwan.; Duvic, M.A.; Raimer, S.S., 2002:
Alopecia, hypohidrosis, and ulcerations in a man: mycosis fungoides

Miteva, L., 2001:
Alopecia: a rare manifestation of lupus vulgaris

Templeton, S.F.; Santa Cruz, D.J.; Solomon, A.R., 1996:
Alopecia: histologic diagnosis by transverse sections

Sawaya, M.E.; Shapiro, J., 2000:
Alopecia: unapproved treatments or indications

Brosius, A.D..; Overman, L.E.., 1997:
Aloperine: Stereocontrolled Synthesis of Two Stereoisomers and Determination of Absolute Configuration

Bia, A., 2002:
Alopex-B: a new, simpler, but yet faster version of the alopex training algorithm

Anonymous, 2000:
Alosetron (Lotronex) for treatment of irritable bowel syndrome

Shen, B.; Soffer, E.E., 2003:
Alosetron (Lotronex) is back: should I use it to treat my patients with irritable bowel syndrome?

Anonymous, 2002:
Alosetron (lotronex) revisited

Miller, J.L., 2000:
Alosetron approved for treatment of irritable bowel syndrome

Lembo, T.; Wright, R.A.; Bagby, B.; Decker, C.; Gordon, S.; Jhingran, P.; Carter, E., 2001:
Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome

Lièvre, M., 2002:
Alosetron for irritable bowel syndrome

Palmer, R.H., 2003:
Alosetron for irritable bowel syndrome. Risks of using alosetron are still unknown

Watson, M.E.; Lacey, L.; Kong, S.; Northcutt, A.R.; McSorley, D.; Hahn, B.; Mangel, A.W., 2001:
Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome

McColl, K.E., 2000:
Alosetron in irritable bowel syndrome

Young, D., 2002:
Alosetron to return to market

Thompson, C.A., 2001:
Alosetron withdrawn from market

Kupecz, D., 2000:
Alosetron: a new therapy for irritable bowel syndrome

Alouani; Wilkins; Albers; Wills, 1994:
Alouani et al. Reply

Noe, S.; Jaeger, H.; Heldwein, S., 2018:
Adrenal insufficiency due to ritonavir-triamcinolone drug-drug interaction without preceding Cushing's syndrome

Nakamura, M., 2002:
Alpers' syndrome

Nishihara, S.; Yazawa, S.; Iwasaki, H.; Nakazato, M.; Kudo, T.; Ando, T.; Narimatsu, H., 1993:
Alpha (1,3/1,4)fucosyltransferase (FucT-III) gene is inactivated by a single amino acid substitution in Lewis histo-blood type negative individuals

Marcelle, R., 1996:
Alpha 1 adrenergic bronchomotor tone in guinea-pigs

Okazaki, M.; Hu, Z.W.; Fujinaga, M.; Hoffman, B.B., 1996:
Alpha 1 adrenergic receptor activation of proto-oncogene expression in arterial smooth muscle: regulation by nitric oxide and vascular injury

Okazaki, M.; Hu, Z.W.; Fujinaga, M.; Hoffman, B.B., 1994:
Alpha 1 adrenergic receptor-induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells

Weesner, G.D.; Krey, L.C.; Pfaff, D.W., 1993:
Alpha 1 adrenergic regulation of estrogen-induced increases in luteinizing hormone-releasing hormone mRNA levels and release

Gambassi, G.; Carbonin, P., 1993:
Alpha 1 adrenergic stimulation, calcium, and arrhythmias

Lepor, H.; Tang, R.; Meretyk, S.; Shapiro, E., 1993:
Alpha 1 adrenoceptor subtypes in the human prostate

Morton, M.E.; Cassidy, T.N.; Froehner, S.C.; Gilmour, B.P.; Laurens, R.L., 1994:
Alpha 1 and alpha 2 Ca2+ channel subunit expression in human neuronal and small cell carcinoma cells

Vigue, B.; Ghaleh, B.; Giudicelli, J.F.; Berdeaux, A., 1993:
Alpha 1 and alpha 2-adrenergic control of large and small coronary arteries during exercise in conscious dogs under beta-blockade

Rehn, M.; Pihlajaniemi, T., 1994:
Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen

Shetterly, S.; Tom, I.; Yen, T.Y.; Joshi, R.; Lee, L.; Wang, P.G.; Macher, B.A., 2001:
Alpha 1,3 galactosyltransferase: new sequences and characterization of conserved cysteine residues

Stults, C.L.; Larsen, R.D.; Macher, B.A., 1995:
Alpha 1,4galactosyltransferase activity and Gb3Cer expression in human leukaemia/lymphoma cell lines

Takemura, H.; Kimura, H.; Hatta, S.; Amemiya, N.; Kawana, S.; Imoto, K.; Ohshika, H., 1996:
Alpha 1- and beta-adrenergic and muscarinic-cholinergic regulation in the spontaneous beating and Ca2+ oscillations in cultured neonatal rat cardiac myocytes

Rosenblum, N.D.; Briscoe, D.M.; Karnovsky, M.J.; Olsen, B.R., 1993:
Alpha 1-VIII collagen is expressed in the rat glomerulus and in resident glomerular cells

Garrido, M.J.; Aguirre, C.; Trocóniz, I.F.; Marot, M.; Valle, M.; Zamacona, M.K.; Calvo, R., 2000:
Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome

Brambilla, G.; Fiori, M.; Curiel, I.; Serpe, L.; Gallo, P., 1999:
Alpha 1-acid glycoprotein affinity columns for the clean-up of adrenergic drugs

Van Molle, W.; Libert, C.; Fiers, W.; Brouckaert, P., 1997:
Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice

Nakamura, T.; Board, P.G.; Matsushita, K.; Tanaka, H.; Matsuyama, T.; Matsuda, T., 1993:
Alpha 1-acid glycoprotein expression in human leukocytes: possible correlation between alpha 1-acid glycoprotein and inflammatory cytokines in rheumatoid arthritis

Oie, S.; Jacobson, M.A.; Abrams, D.I., 1993:
Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV)

Boffito, M.; Sciole, K.; Raiteri, R.; Bonora, S.; Hoggard, P.G.; Back, D.J.; D.P.rri, G., 2002:
Alpha 1-acid glycoprotein levels in human immunodeficiency virus-infected subjects on antiretroviral regimens

Tagawa, Y.; Kokue, E.; Shimoda, M.; Son, D.S., 1994:
Alpha 1-acid glycoprotein-binding as a factor in age-related changes in the pharmacokinetics of trimethoprim in piglets

García-Sáinz, J.A., 1993:
Alpha 1-adrenergic action: receptor subtypes, signal transduction and regulation

Chen, L.; el-Sherif, N.; Boutjdir, M., 1996:
Alpha 1-adrenergic activation inhibits beta-adrenergic-stimulated unitary Ca2+ currents in cardiac ventricular myocytes

Dartt, D.A.; Rose, P.E.; Dicker, D.M.; Ronco, L.V.; Hodges, R.R., 1994:
Alpha 1-adrenergic agonist-stimulated protein secretion in rat exorbital lacrimal gland acini

Borst, S.E.; Oliver, R.J.; Scarpace, P.J., 1994:
Alpha 1-adrenergic and arginine vasopressin stimulation of inositide hydrolysis in rat hepatocytes is unaltered in senescence

Ota, I.; Zoukhri, D.; Hodges, R.R.; Rios, Jé.D.; Tepavcevic, V.; Raddassi, I.; Chen, L.Li.; Dartt, D.A., 2002:
Alpha 1-adrenergic and cholinergic agonists activate MAPK by separate mechanisms to inhibit secretion in lacrimal gland

Wong, K.R.; Berry, C.A.; Cogan, M.G., 1996:
Alpha 1-adrenergic control of chloride transport in the rat S1 proximal tubule

Muyderman, H.; Angehagen, M.; Sandberg, M.; Björklund, U.; Olsson, T.; Hansson, E.; Nilsson, M., 2001:
Alpha 1-adrenergic modulation of metabotropic glutamate receptor-induced calcium oscillations and glutamate release in astrocytes

Shivapuja, B.G.; Ray, S.M.; Saunders, S.S.; Schoener, E.P., 1995:
Alpha 1-adrenergic receptor antagonist blocks acute cocaine action on the compound action potential of the auditory nerve in the chinchilla

Luther, H.P.; Homuth, V.; Wallukat, G., 1997:
Alpha 1-adrenergic receptor antibodies in patients with primary hypertension

Hwang, K.C.; Gray, C.D.; Sweet, W.E.; Moravec, C.S.; Im, M.J., 1996:
Alpha 1-adrenergic receptor coupling with Gh in the failing human heart

Michelotti, G.A.; Price, D.T.; Schwinn, D.A., 2001:
Alpha 1-adrenergic receptor regulation: basic science and clinical implications

Hamaguchi, N.; True, T.A.; Goetz, A.S.; Stouffer, M.J.; Lybrand, T.P.; Jeffs, P.W., 1998:
Alpha 1-adrenergic receptor subtype determinants for 4-piperidyl oxazole antagonists

Minneman, K.P.; Esbenshade, T.A., 1994:
Alpha 1-adrenergic receptor subtypes

Liu, S.Y.; Pitovski, D.Z.; Shivapuja, B.G., 1996:
Alpha 1-adrenergic receptors in the mammalian cochlea

Kester, M.; Liedtke, C.M., 1996:
Alpha 1-adrenergic stimulation differentially regulates ether-linked diacylglycerols in airway epithelial cells from normal and cystic fibrosis patients

Yamashita, N.; Nishida, M.; Hoshida, S.; Igarashi, J.; Hori, M.; Kuzuya, T.; Tada, M., 1996:
Alpha 1-adrenergic stimulation induces cardiac tolerance to hypoxia via induction and activation of Mn-SOD

Wu, P.S.; Moriscot, A.S.; Knowlton, K.U.; Hilal-Dandan, R.; He, H.; Dillmann, W.H., 1997:
Alpha 1-adrenergic stimulation inhibits 3,5,3'-triiodothyronine-induced expression of the rat heart sarcoplasmic reticulum Ca2+ adenosine triphosphatase gene

Bruneau, B.G.; Piazza, L.A.; de Bold, A.J., 1996:
Alpha 1-adrenergic stimulation of isolated rat atria results in discoordinate increases in natriuretic peptide secretion and gene expression and enhances Egr-1 and c-Myc expression

Meij, J.T.; Dhalla, V.; Panagia, V., 1994:
Alpha 1-adrenergic stimulation of phospholipase C activity in purified cardiac sarcolemmal membranes

Kitakaze, M.; Hori, M.; Morioka, T.; Minamino, T.; Takashima, S.; Sato, H.; Shinozaki, Y.; Chujo, M.; Mori, H.; Inoue, M., 1994:
Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity

Helliwell, R.M.; Large, W.A., 1997:
Alpha 1-adrenoceptor activation of a non-selective cation current in rabbit portal vein by 1,2-diacyl-sn-glycerol

Pucéat, M.; Clément-Chomienne, O.; Terzic, A.; Vassort, G., 1993:
Alpha 1-adrenoceptor and purinoceptor agonists modulate Na-H antiport in single cardiac cells

Riekkinen, P.; Sirviö, J.; Toivanen, L.; Riekkinen, M.; Lammintausta, R.; Riekkinen, P., 1993:
Alpha 1-adrenoceptor antagonist decreases alpha 2-adrenoceptor antagonist-induced high voltage spindle suppression in adult and aged rats

Rouquier, L.; Claustre, Y.; Benavides, J., 1994:
Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study

Dunn-Meynell, A.A.; Yarlagadda, Y.; Levin, B.E., 1997:
Alpha 1-adrenoceptor blockade increases behavioral deficits in traumatic brain injury

Ford, A.P.; Williams, T.J.; Blue, D.R.; Clarke, D.E., 1994:
Alpha 1-adrenoceptor classification: sharpening Occam's razor

Lin, M.J.; Jia, B.J., 1993:
Alpha 1-adrenoceptor involved in the process of VSMp control of renal sympathetic nerve activities in spinal cord in rats

Andersen, G.O.; Enger, M.; Skomedal, T.; Osnes, J.B., 1997:
Alpha 1-adrenoceptor mediated activation of Na/K/2Cl cotransport and K+ channels in the rat heart involves different receptor subtypes

Hattori, Y.; Nagashima, M.; Akaishi, Y.; Kanno, M., 1996:
Alpha 1-adrenoceptor subtype distribution and the coupling to phosphoinositide hydrolysis in rat and rabbit ventricular myocardium

Yazawa, H.; Honda, K., 1993:
Alpha 1-adrenoceptor subtype in the rat prostate is preferentially the alpha 1A type

Nagashima, M.; Hattori, Y.; Tohse, N.; Kanno, M., 1997:
Alpha 1-adrenoceptor subtype involved in the positive and negative inotropic responses to phenylephrine in rat papillary muscle

Noguchi, H.; Muraoka, R.; Kigoshi, S.; Muramatsu, I., 1993:
Alpha 1-adrenoceptor subtype involved in the positive inotropic response to phenylephrine in rat atria

De Benedetti, P.G.; Fanelli, F.; Menziani, M.C.; Cocchi, M.; Testa, R.; Leonardi, A., 1997:
Alpha 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships

Oriowo, M.A., 1994:
Alpha 1-adrenoceptor subtype(s) mediating noradrenaline-induced contractions of the guinea-pig aorta

Stassen, F.R.; Willemsen, M.J.; Janssen, G.M.; DeMey, J.G., 1997:
Alpha 1-adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post-myocardial infarction

Michel, M.C.; Taguchi, K.; Schäfers, R.S.; Williams, T.J.; Clarke, D.E.; Ford, A.P., 1997:
Alpha 1-adrenoceptor subtypes in the human cardiovascular and urogenital systems

Viko, H.; Osnes, J.B.; Sandnes, D.; Skomedal, T., 1997:
Alpha 1-adrenoceptor subtypes involved in increased 86Rb+ influx rate and inositol 1,4,5-trisphosphate mass in adult rat cardiomyocytes

Nagashima, M.; Hattori, Y.; Akaishi, Y.; Tohse, N.; Sakuma, I.; Kitabatake, A.; Kanno, M., 1996:
Alpha 1-adrenoceptor subtypes mediating inotropic and electrophysiological effects in mammalian myocardium

Queiroz-Neto, A.; Ballejo, G., 1993:
Alpha 1-adrenoceptor subtypes mediating the norepinephrine-induced contractile response in the rat vas deferens

Ito, K.; Murakami, K.; Tamura, K., 1993:
Alpha 1-adrenoceptor-blocking activity of ofloxacin and ciprofloxacin in isolated vascular smooth muscles

Buckner, S.A.; Oheim, K.W.; Morse, P.A.; Knepper, S.M.; Hancock, A.A., 1996:
Alpha 1-adrenoceptor-induced contractility in rat aorta is mediated by the alpha 1D subtype

Bültmann, R.; Kurz, A.K.; Starke, K., 1994:
Alpha 1-adrenoceptors and calcium sources in adrenergic neurogenic contractions of rat vas deferens

Fedida, D.; Braun, A.P.; Giles, W.R., 1993:
Alpha 1-adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms

Kawana, S.; Kimura, H.; Miyamoto, A.; Ohshika, H.; Namiki, A., 1993:
Alpha 1-adrenoceptors in neonatal rat cardiac myocytes: hypoxia alters the responsiveness of alpha 1A and alpha 1B subtypes

Dunn-Meynell, A.A.; Levin, B.E., 1993:
Alpha 1-adrenoceptors in the adult rat barrel field: effects of deafferentation and norepinephrine removal

Saito, K.; Suetsugu, T.; Oku, Y.; Kuroda, A.; Tanaka, H., 1994:
Alpha 1-adrenoceptors in the conduction system of rat hearts

Takeda, M.; Hatano, A.; Takahashi, H.; Tamaki, M.; Komeyama, T.; Koizumi, T.; Tsutsui, T., 1993:
Alpha 1-adrenoceptors in the human prostatic urethra are different from those of the human peripheral arteries

Villalobos-Molina, R.; Ibarra, M., 1996:
Alpha 1-adrenoceptors mediating contraction in arteries of normotensive and spontaneously hypertensive rats are of the alpha 1D or alpha 1A subtypes

García-Sáinz, J.A.; Vázquez-Prado, J.; del Carmen Medina, L., 2000:
Alpha 1-adrenoceptors: function and phosphorylation

Hieble, J.P.; Ruffolo, R.R., 1994:
Alpha 1-adrenoceptors: pharmacological subclassification and therapeutic applications

García-Sáinz, J.A.; Vázquez-Prado, J.; Villalobos-Molina, R., 2000:
Alpha 1-adrenoceptors: subtypes, signaling, and roles in health and disease

Melchiorre, C.; Angeli, P.; Bolognesi, M.L.; Chiarini, A.; Giardinà, D.; Gulini, U.; Leonardi, A.; Marucci, G.; Minarini, A.; Pigini, M.; Quaglia, W.; Rosini, M.; Tumiatti, V., 2000:
Alpha 1-adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moiety

Kalsheker, N.A., 1996:
Alpha 1-antichymotrypsin

Mashige, F.; Miyake, K., 1995:
Alpha 1-antichymotrypsin (ACT)

Pirttila, T.; Mehta, P.D.; Frey, H.; Wisniewski, H.M., 1994:
Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease

Fraser, P.E.; Nguyen, J.T.; McLachlan, D.R.; Abraham, C.R.; Kirschner, D.A., 1993:
Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro

Mannello, F.; Malatesta, M.; Bocchiotti, G.; Gazzanelli, G., 1994:
Alpha 1-antichymotrypsin complexes in human breast cyst fluids

Muramatsu, T.; Matsushita, S.; Arai, H.; Sasaki, H.; Higuchi, S., 1996:
Alpha 1-antichymotrypsin gene polymorphism and risk for Alzheimer's disease

Abraham, C.R.; McGraw, W.T.; Slot, F.; Yamin, R., 2001:
Alpha 1-antichymotrypsin inhibits A beta degradation in vitro and in vivo

Aksenov, M.Y.; Aksenova, M.V.; Carney, J.M.; Butterfield, D.A., 1996:
Alpha 1-antichymotrypsin interaction with A beta (1-42) does not inhibit fibril formation but attenuates the peptide toxicity

Twining, S.S.; Fukuchi, T.; Yue, B.Y.; Wilson, P.M.; Zhou, X., 1994:
Alpha 1-antichymotrypsin is present in and synthesized by the cornea

Bilak, M.; Askanas, V.; Engel, W.K., 1994:
Alpha 1-antichymotrypsin is strongly immunolocalized at normal human and rat neuromuscular junctions

Sandford, A.J.; Chagani, T.; Weir, T.D.; Paré, P.D., 1998:
Alpha 1-antichymotrypsin mutations in patients with chronic obstructive pulmonary disease

Eriksson, S.; Janciauskiene, S.; Lannfelt, L., 1995:
Alpha 1-antichymotrypsin regulates Alzheimer beta-amyloid peptide fibril formation

Pountain, G.D.; Calvin, J.; Hazleman, B.L., 1994:
Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis

Reiter, W.; Stieber, P.; Schmeller, N.; Nagel, D.; Fateh-Moghadam, A., 1998:
Alpha 1-antichymotrypsin-PSA (ACT-PSA): a useful marker in the differential diagnosis of benign hyperplasia and cancer of the prostate?

Ritscher, D.; Russi, E.W., 1999:
Alpha 1-antiproteinase deficiency

Lomas, D.A.; Finch, J.T.; Seyama, K.; Nukiwa, T.; Carrell, R.W., 1993:
Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization

Xia, Z.; Wang, G.; Ge, S.; Tian, J., 2002:
Alpha 1-antitrypsin and alpha 1-acid glycoprotein reduce the sensitivity of human dermal fibroblast to endotoxin

Yavelow, J.; Tuccillo, A.; Kadner, S.S.; Katz, J.; Finlay, T.H., 1997:
Alpha 1-antitrypsin blocks the release of transforming growth factor-alpha from MCF-7 human breast cancer cells

Nagayama, R.; Miyake, K., 1997:
Alpha 1-antitrypsin clearance

Mowat, A.P., 1994:
Alpha 1-antitrypsin deficiency (PiZZ): features of liver involvement in childhood

Kadono, K.; Sakamoto, T.; Ohtsuka, M.; Kanashiki, M.; Murakami, O.; Hagiya, M.; Ishii, Y.; Nomura, A.; Satoh, H.; Inoue, M.; Uchida, Y.; Homma, T.; Sekizawa, K.; Hasegawa, S., 1999:
Alpha 1-antitrypsin deficiency (Siiyama) with pulmonary emphysema

Huggard, P.R.; West, M.J.; Summers, K.M., 1996:
Alpha 1-antitrypsin deficiency alleles and blood pressure in an Australian population

Pina, J.S.; Horan, M.P., 1997:
Alpha 1-antitrypsin deficiency and asthma. The continuing search for the relationship

Scharnweber, K., 2000:
Alpha 1-antitrypsin deficiency and the impact of nursing interventions and treatment with intravenous therapy. An overview

Browne, R.J.; Mannino, D.M.; Khoury, M.J., 1996:
Alpha 1-antitrypsin deficiency deaths in the United States from 1979-1991. An analysis using multiple-cause mortality data

Hutchison, D.C., 1998:
Alpha 1-antitrypsin deficiency in Europe: geographical distribution of Pi types S and Z

Seyama, K.; Nukiwa, T.; Kira, S., 1996:
Alpha 1-antitrypsin deficiency in Japan

Skoda-Smith, S.; Mroczek-Musulman, E.; Galliani, C.; Atkinson, T.P.; Watts, R.G., 1997:
Alpha 1-antitrypsin deficiency in a child with X-linked lymphoproliferative disease

Schievink, W.I.; Prakash, U.B.; Piepgras, D.G.; Mokri, B., 1994 :
Alpha 1-antitrypsin deficiency in intracranial aneurysms and cervical artery dissection

Stejskal, J.; Pijácková, A.; Dolezel, Z.; Husek, K., 1993:
Alpha 1-antitrypsin deficiency--a hereditary storage disease of the hepatic endoplasmic reticulum

Carrell, R.W.; Lomas, D.A.; Sidhar, S.; Foreman, R., 1996:
Alpha 1-antitrypsin deficiency. A conformational disease

Wulfsberg, E.A.; Hoffmann, D.E.; Cohen, M.M., 1994:
Alpha 1-antitrypsin deficiency. Impact of genetic discovery on medicine and society

van Steenbergen, W., 1993:
Alpha 1-antitrypsin deficiency: an overview

King, M.A.; Stone, J.A.; Diaz, P.T.; Mueller, C.F.; Becker, W.J.; Gadek, J.E., 1996:
Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT

Anonymous, 1997:
Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting

Pini, L.; Corda, L.; Malerba, M.; Montanelli, A.; Favagrossa, G.M.; Terzi, A.; Marcobruni, N.; Magoni, M.; Franchini, D.; Radaeli, A.; Tantucci, C.; Grassi, V., 2000:
Alpha 1-antitrypsin deficiency: the Brescia clinical study

Poblete, M.T.; Nualart, F.; del Pozo, M.; Perez, J.A.; Figueroa, C.D., 1996:
Alpha 1-antitrypsin expression in human thyroid papillary carcinoma

Bessho, H.; Nanjo, K., 1998:
Alpha 1-antitrypsin in patients with diabetes mellitus

Ray, D.; Sri Krishna, K., 1993:
Alpha 1-antitrypsin in tropical pulmonary eosinophilia

Lee, J.; Novoradovskaya, N.; Rundquist, B.; Redwine, J.; Saltini, C.; Brantly, M., 1998:
Alpha 1-antitrypsin nonsense mutation associated with a retained truncated protein and reduced mRNA

Chongsrisawat, V.; Jantaradsamee, P.; Vivatvakin, B.; Pongpaew, P.; Poovorawan, Y., 1998:
Alpha 1-antitrypsin phenotype of children with liver diseases in Thailand

Monteseirín, J.; Prados, M.; Conde, J., 1994:
Alpha 1-antitrypsin phenotypes and bronchial asthma

Bourke, M.; O'Donovan, M.; Stevens, F.M.; McCarthy, C.F., 1993:
Alpha 1-antitrypsin phenotypes in coeliac patients and a control population in the west of Ireland

Bottomley, S.P.; Hopkins, P.C.; Whisstock, J.C., 1998:
Alpha 1-antitrypsin polymerisation can occur by both loop A and C sheet mechanisms

Koppel, R.; Han, R.N.; Cox, D.; Tanswell, A.K.; Rabinovitch, M., 1994:
Alpha 1-antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity

Seyama, K.; Nukiwa, T.; Souma, S.; Shimizu, K.; Kira, S., 1995:
Alpha 1-antitrypsin-deficient variant Siiyama (Ser53[TCC] to Phe53[TTC]) is prevalent in Japan. Status of alpha 1-antitrypsin deficiency in Japan

Schwaiblmair, M.; Vogelmeier, C., 1998:
Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers?

Cox, D.W., 1994 :
Alpha 1-antitrypsin: a guardian of vascular tissue

Massi, G.; Chiarelli, C., 1994:
Alpha 1-antitrypsin: molecular structure and the Pi system

Itskovitz, H.D., 1994:
Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings

Horky, K., 1993:
Alpha 1-blockade in the management of hypertension

Houston, M.C., 1998:
Alpha 1-blocker combination therapy for hypertension

Sever, P.S., 1999:
Alpha 1-blockers in hypertension

Blohm, M.E.; Vesterling-Hörner, D.; Calaminus, G.; Göbel, U., 1998:
Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age

del Castillo-Olivares, A.; Gil, G., 2000:
Alpha 1-fetoprotein transcription factor is required for the expression of sterol 12alpha -hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription

Ferrantini, M.; Proietti, E.; Santodonato, L.; Gabriele, L.; Peretti, M.; Plavec, I.; Meyer, F.; Kaido, T.; Gresser, I.; Belardelli, F., 1993:
Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells

Itoh, Y., 1999:
Alpha 1-microglobulin

Itoh, Y., 2002:
Alpha 1-microglobulin, beta 2-microglobulin

Köhnlein, T.; Klein, H.; Welte, T., 1999:
Alpha 1-protease inhibitor deficiency. Diagnosis, follow-up and therapy options

Horowitz, I.D., 1996:
Alpha 1-proteinase inhibitor (human) shortage

Rodrigues-Lima, F.; Hermann, J.; Jean, D.; Frade, R., 1998:
Alpha 1-proteinase inhibitor is the serum regulator of the activity of p57, a C3-cleaving proteinase present in human erythrocyte membranes

Johannssen, V.; Maune, S.; Werner, J.A.; Rudert, H.; Ziegler, A., 1998:
Alpha 1-receptors at pre-capillary resistance vessels of the human nasal mucosa

Smith, M.A.; Kalaria, R.N.; Perry, G., 1993:
Alpha 1-trypsin immunoreactivity in Alzheimer disease

Knoops, B.; Octave, J.N., 1997:
Alpha 1-tubulin mRNA level is increased during neurite outgrowth of NG 108-15 cells but not during neurite outgrowth inhibition by CNS myelin

Michel, M.C.; Büscher, R.; Philipp, T.; Brodde, O.E., 1993:
Alpha 1A and alpha 1B-adrenoceptors enhance inositol phosphate generation in rat renal cortex

Meucci, O.; Scorziello, A.; Avallone, A.; Ventra, C.; Grimaldi, M.; Berlingieri, M.T.; Fusco, A.; Schettini, G., 1994:
Alpha 1A- and alpha 1B-adrenergic receptors mediate the effect of norepinephrine on cytosolic calcium levels in rat PC C13 thyroid cells: thyrotropin modulation of alpha 1B-linked response via a adenosine 3',5'-monophosphate-protein kinase-A-dependent pathway

Hua, Z.; Wang, X.L., 1993:
Alpha 1A- and alpha 1B-adrenoceptor-mediated positive chronotropic effects on isolated rat atrium

Furukawa, K.; Rosario, D.J.; Smith, D.J.; Chapple, C.R.; Uchiyama, T.; Chess-Williams, R., 1995:
Alpha 1A-adrenoceptor-mediated contractile responses of the human vas deferens

Canessa, L.M.; Piccio, M.M.; Vachvanichsanong, P.; Sidhu, A.; Porter, C.C.; Robillard, J.E.; Felder, R.A.; Jose, P.A., 1995:
Alpha 1B-adrenergic receptors in rat renal microvessels

Feng, J.F.; Gray, C.D.; Im, M.J., 1999:
Alpha 1B-adrenoceptor interacts with multiple sites of transglutaminase II: characteristics of the interaction in binding and activation

Furukawa, K.; Chess-Williams, R.; Uchiyama, T., 1996:
Alpha 1B-adrenoceptor subtype mediating the phenylephrine-induced contractile response in rabbit corpus cavernosum penis

Marek, G.J.; Aghajanian, G.K., 1996:
Alpha 1B-adrenoceptor-mediated excitation of piriform cortical interneurons

Nomura, T.; Kondo, H.; Hasegawa, S.; Watanabe, T.; Yokoyama, R.; Ukai, K.; Tachibana, M.; Sumi-Ichinose, C.; Nomura, H.; Hagino, Y., 1993:
Alpha 1B-adrenoceptor-mediated stimulation of Ca2+ mobilization and cAMP accumulation in isolated rat hepatocytes

Chik, C.L.; Liu, Q.Y.; Li, B.; Klein, D.C.; Zylka, M.; Kim, D.S.; Chin, H.; Karpinski, E.; Ho, A.K., 1997:
Alpha 1D L-type Ca(2+)-channel currents: inhibition by a beta-adrenergic agonist and pituitary adenylate cyclase-activating polypeptide (PACAP) in rat pinealocytes

Villalobos-Molina, R.; López-Guerrero, J.J.; Ibarra, M., 1997:
Alpha 1D- and alpha 1A-adrenoceptors mediate contraction in rat renal artery

Deng, X.F.; Varma, D.R., 1997:
Alpha 1D-adrenoceptors do not contribute to inotropic responses of neonatal rat myocardium

Wang, S.N.; Fontenot, H.J.; Kennedy, R.H., 1997:
Alpha 1D-adrenoceptors play little role in the positive inotropic action of phenylephrine

Allen, J.C.; Zhao, X.; Odebunmi, T.; Jemelka, S.; Medford, R.M.; Pressley, T.A.; Mercer, R.W., 1997:
Alpha 1T can support Na+,K(+)-ATPase: Na+ pump functions in expression systems

Shibata, K.; Hirasawa, A.; Moriyama, N.; Kawabe, K.; Ogawa, S.; Tsujimoto, G., 1996:
Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy

Awaji, T.; Izumi, S.; Horie, K.; Hirasawa, A.; Tsujimoto, G., 1996:
Alpha 1b-adrenoceptor-mediated calcium oscillation is specific for the S phase in cell cycle and dependent on the extracellular calcium

Williamson, A.P.; Kennedy, R.H.; Seifen, E.; Lindemann, J.P.; Stimers, J.R., 1993:
Alpha 1b-adrenoceptor-mediated stimulation of Na-K pump current in adult rat ventricular myocytes

Elhawary, A.M.; Pang, C.C., 1994:
Alpha 1b-adrenoceptors mediate renal tubular sodium and water reabsorption in the rat

Newcorn, J.H.; Schulz, K.; Harrison, M.; DeBellis, M.D.; Udarbe, J.K.; Halperin, J.M., 1999:
Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children

Hayashi, Y.; Maze, M., 1993:
Alpha 2 adrenoceptor agonists and anaesthesia

England, G.C.; Clarke, K.W., 1996:
Alpha 2 adrenoceptor agonists in the horse--a review

Paddleford, R.R.; Harvey, R.C., 1999:
Alpha 2 agonists and antagonists

Kapoor, R.; Chapman, I.M.; Willoughby, J.O., 1993:
Alpha 2 and beta adrenoceptors in the mediobasal hypothalamus and alpha 2 adrenoceptors in the preoptic-anterior hypothalamus stimulate prolactin secretion in the conscious male rat

Vallés, A.M.; Boyer, B.; Tarone, G.; Thiery, J.P., 1996:
Alpha 2 beta 1 integrin is required for the collagen and FGF-1 induced cell dispersion in a rat bladder carcinoma cell line

Chen, M.; O'Toole, E.A.; Li, Y.Y.; Woodley, D.T., 1999:
Alpha 2 beta 1 integrin mediates dermal fibroblast attachment to type VII collagen via a 158-amino-acid segment of the NC1 domain

Rose, A.M.; Mellett, B.J.; Valdes, R.; Kleinman, J.E.; Herman, M.M.; Li, R.; el-Mallakh, R.S., 1998:
Alpha 2 isoform of the Na,K-adenosine triphosphatase is reduced in temporal cortex of bipolar individuals

Ohtani, H.; Kanoh, Y., 1999:
Alpha 2 macroglobulin

Witschi, H., 1997:
Alpha 2 mu, alpha 2u, or alpha 2u

Ashby, J., 1996:
Alpha 2 mu-globulin nephropathy in white ravens

Sanchez, M.; Gionti, E.; Arcella, A.; Pontarelli, G.; De Lorenzo, F., 1993:
Alpha 2(I) collagen gene expression is up-regulated in quail chondrocytes pretreated with retinoic acid

Hamr, A.; Vlasáková, V.; Kolínská, J., 1993:
Alpha 2,6-sialyltransferase predominates in cultured jejunum of suckling rats: it is up-regulated by dexamethasone and secreted during cultivation

Daniels, W.M.; Jaffer, A.; Russell, V.A.; Taljaard, J.J., 1993:
Alpha 2- and beta-adrenergic stimulation of corticosterone secretion in rats

Akamatsu, S.; Yazawa, S.; Tachikawa, T.; Furuta, T.; Okaichi, Y.; Nakamura, J.; Asao, T.; Nagamachi, Y., 1996:
Alpha 2-->3sialyltransferase associated with the synthesis of CA 19-9 in colorectal tumors

Cai, J.J.; Morgan, D.A.; Haynes, W.G.; Martins, J.B.; Lee, H-Chi., 2002:
Alpha 2-Adrenergic stimulation is protective against ischemia-reperfusion-induced ventricular arrhythmias in vivo

Del Rio, G.; Zizzo, G.; Marrama, P.; Venneri, M.G.; Della Casa, L.; Velardo, A., 1994:
Alpha 2-adrenergic activity is normal in patients with thyroid disease

Fale, A.; Kirsch, J.R.; McPherson, R.W., 1994:
Alpha 2-adrenergic agonist effects on normocapnic and hypercapnic cerebral blood flow in the dog are anesthetic dependent

Lockette, W.; Kirkland, K.; Farrow, S., 1996:
Alpha 2-adrenergic agonists increase cellular lactate efflux

Wen, R.; Cheng, T.; Li, Y.; Cao, W.; Steinberg, R.H., 1996:
Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage

Bickler, P.E.; Hansen, B.M., 1996:
Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia

Huangfu, D.; Guyenet, P.G., 1997:
Alpha 2-adrenergic autoreceptors in A5 and A6 neurons of neonate rats

Alvarez, C.; Bladé, C.; Cartañà, J., 1993:
Alpha 2-adrenergic blockade prevents hyperglycemia and hepatic glutathione depletion in nickel-injected rats

Millan, M.J., 1997:
Alpha 2-adrenergic mechanisms of analgesia: strategies for improving their therapeutic window and identification of the novel, potent alpha 2A-adrenergic receptor agonist, S 18616

Bharucha, A.E.; Novak, V.; Camilleri, M.; Zinsmeister, A.R.; Hanson, R.B.; Low, P.A., 1997:
Alpha 2-adrenergic modulation of colonic tone during hyperventilation

Supowit, S.C.; Hallman, D.M.; Zhao, H.; DiPette, D.J., 1998:
Alpha 2-adrenergic receptor activation inhibits calcitonin gene-related peptide expression in cultured dorsal root ganglia neurons

Gold, M.S.; Dastmalchi, S.; Levine, J.D., 1997:
Alpha 2-adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons

MacMillan, L.B.; Lakhlani, P.; Lovinger, D.; Limbird, L.E., 1998:
Alpha 2-adrenergic receptor subtypes: subtle mutation of the alpha 2A-adrenergic receptor in vivo by gene targeting strategies reveals the role of this subtype in multiple physiological settings

Gesek, F.A., 1996:
Alpha 2-adrenergic receptors activate phospholipase C in renal epithelial cells

Richman, J.G.; Regan, J.W., 1998:
Alpha 2-adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells

Trendelenburg, A.U.; Limberger, N.; Rump, L.C., 1994:
Alpha 2-adrenergic receptors of the alpha 2c subtype mediate inhibition of norepinephrine release in human kidney cortex

Bouloumié, A.; Planat, V.; Devedjian, J.C.; Valet, P.; Saulnier-Blache, J.S.; Record, M.; Lafontan, M., 1994:
Alpha 2-adrenergic stimulation promotes preadipocyte proliferation. Involvement of mitogen-activated protein kinases

Liedtke, C.M.; Furin, J.; Ernsberger, P., 1993:
Alpha 2-adrenergic, but not imidazole, agonists activate NaCl cotransport in rabbit tracheal epithelial cells

Rouch, A.J.; Kudo, L.H., 1996:
Alpha 2-adrenergic-mediated inhibition of water and urea permeability in the rat IMCD

Ekelund, U.; Björnberg, J.; Mellander, S., 1998:
Alpha 2-adrenoceptor activation may trigger the increased production of endothelium-derived nitric oxide in skeletal muscle during acute haemorrhage

Masuda, Y.; Ohnuma, S.; Sugiyama, T., 2001:
Alpha 2-adrenoceptor activity induces the antidepressant-like glycolipid in mouse forced swimming

Halonen, T.; Kotti, T.; Tuunanen, J.; Toppinen, A.; Miettinen, R.; Riekkinen, P.J., 1995:
Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage

De Kock, M.; Meert, T.F., 1997:
Alpha 2-adrenoceptor agonists and stress-induced analgesia in rats: influence of stressors and methods of analysis

Allen, D.E.; Gellai, M., 1993:
Alpha 2-adrenoceptor antagonism attenuates the diuretic response to acute cold exposure

Berlan, M.; Le Verge, R.; Galitzky, J.; Le Corre, P., 1993:
Alpha 2-adrenoceptor antagonist potencies of two hydroxylated metabolites of yohimbine

Camacho, F.; Smith, C.P.; Vargas, H.M.; Winslow, J.T., 1996:
Alpha 2-adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat

Yonezawa, A.; Ando, R.; Watanabe, C.; Furuta, S.; Kutsuwa, M.; Sakurada, S.; Kimura, Y., 2001:
Alpha 2-adrenoceptor antagonists: effects on ejaculation, penile erection and pelvic thrusting behavior in dogs

Ventura, S.; Pennefather, J.N., 1994:
Alpha 2-adrenoceptor binding sites vary along the length of the male reproductive tract: a possible basis for the regional variation in response to field stimulation

Khanna, S.; Sibbald, J.R.; Day, T.A., 1993:
Alpha 2-adrenoceptor modulation of A1 noradrenergic neuron input to supraoptic vasopressin cells

Penner, S.Brian.; Mueller, H.A.; Smyth, D.D., 2002:
Alpha 2-adrenoceptor stimulation in the periventricular nucleus increases urine flow rate with minimal effects on blood pressure

Sastre, M.; García-Sevilla, J.A., 1994:
Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype

Grijalba, B.; Callado, L.F.; Javier Meana, J.; García-Sevilla, J.A.; Pazos, A., 1996:
Alpha 2-adrenoceptor subtypes in the human brain: a pharmacological delineation of [3H]RX-821002 binding to membranes and tissue sections

Gazzola, C., 1993:
Alpha 2-adrenoceptor-mediated effects on resting energy expenditure

Allen, A.M.; Guyenet, P.G., 1993:
Alpha 2-adrenoceptor-mediated inhibition of bulbospinal barosensitive cells of rat rostral medulla

Piletz, J.E.; Andrew, M.; Zhu, H.; Feng, Y.Z.; Rains, J.; Halaris, A., 1998:
Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age

French, N., 1995:
Alpha 2-adrenoceptors and I2 sites in the mammalian central nervous system

Stenberg, D.; Porkka-Heiskanen, T.; Toppila, J., 1993:
Alpha 2-adrenoceptors and vigilance in cats: antagonism of medetomidine sedation by atipamezole

Thomson, S.C.; Vallon, V., 1995:
Alpha 2-adrenoceptors determine the response to nitric oxide inhibition in the rat glomerulus and proximal tubule

Haynes, J.M.; Adams, G.D.; Pennefather, J.N., 1993:
Alpha 2-adrenoceptors in the guinea-pig uterus: heterogeneity in the circular and longitudinal smooth muscle layers

MacKinnon, A.C.; Spedding, M.; Brown, C.M., 1994:
Alpha 2-adrenoceptors: more subtypes but fewer functional differences

Crook, M.; Crawford, N., 1993:
Alpha 2-adrenoreceptor status of human platelet subpopulations separated by continuous flow electrophoresis

Zelena, D.; Kiem, D.T.; Barna, I.; Makara, G.B., 1999:
Alpha 2-adrenoreceptor subtypes regulate ACTH and beta-endorphin secretions during stress in the rat

Holman, H.E.; Haas, R.E., 1998 :
Alpha 2-agonist agents: a review for CRNAs

Alburges, M.E.; Bylund, D.B.; Pundt, L.L.; Wamsley, J.K., 1993:
Alpha 2-agonist binding sites in brain: [125I]para-iodoclonidine versus [3H]para-aminoclonidine

Harris, S.I.; Alvarez, C., 1997:
Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies

Butte, A.N.; Houng, A.K.; Jang, I.K.; Reed, G.L., 1997:
Alpha 2-antiplasmin causes thrombi to resist fibrinolysis induced by tissue plasminogen activator in experimental pulmonary embolism

Griffin, G.C.; Mammen, E.F.; Sokol, R.J.; Perrotta, A.L.; Stoyanovich, A.; Abildgaard, C.F., 1993:
Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage

Bohmann, C.; Schollmeyer, P.; Rump, L.C., 1993:
Alpha 2-autoreceptor subclassification in rat isolated kidney by use of short trains of electrical stimulation

Cervenakov, I.; Szoldova, K.; Mardiak, J.; Chovan, D.; Mala, M.; Slavov, D., 2000:
Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder

Landin, B.; Berg, P., 1994:
Alpha 2-globin gene mutation Hb G-Waimanalo: occurrence in combination with alpha-thalassemia-1

Turecký, L.; Kupcová, V.; Szántová, M., 1999:
Alpha 2-macroglobulin in the blood of patients with diabetes mellitus

Oka, U.; Nakamura, M.; Kinjoh, K.; Kosugi, T., 1996:
Alpha 2-macroglobulin of rabbits inhibits the habutobin activity

Gouin-Charnet, A.; Mourad, G.; Argilés, A., 1997:
Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation

Hyman, B.T.; Strickland, D.K.; Rebeck, G.W., 1994:
Alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Relationship to apolipoprotein E and role in Alzheimer disease senile plaques

Lauer, D.; Reichenbach, A.; Birkenmeier, G., 2001:
Alpha 2-macroglobulin-mediated degradation of amyloid beta 1--42: a mechanism to enhance amyloid beta catabolism

Feige, J.J.; Negoescu, A.; Keramidas, M.; Souchelnitskiy, S.; Chambaz, E.M., 1996:
Alpha 2-macroglobulin: a binding protein for transforming growth factor-beta and various cytokines

Yoshikawa, Y., 1999:
Alpha 2-plasmin inhibitor-plasmin complex

Raymond, J.R.; Arthur, J.M.; Casañas, S.J.; Olsen, C.L.; Gettys, T.W.; Mortensen, R.M., 1994:
Alpha 2A adrenergic receptors inhibit cAMP accumulation in embryonic stem cells which lack Gi alpha 2

Van Liefde, I.; Vauquelin, G.; De Keyser, J.; De Backer, J.P.; De Vos, H., 1993:
Alpha 2A adrenoceptors and non-adrenergic idazoxan binding sites in calf brain and retina are distinct from those in human brain

Dorn, G.W.; Oswald, K.J.; McCluskey, T.S.; Kuhel, D.G.; Liggett, S.B., 1997:
Alpha 2A-adrenergic receptor stimulated calcium release is transduced by Gi-associated G(beta gamma)-mediated activation of phospholipase C